fRNAdb::Catalog::OMIM

OMIM
Classification by NCBI OMIM (Online Mendelian Inheritance in Man) titles.
 

OMIM Help

1 2 3 4 5   >

TitleLocusfRNAdb Ids
CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1 15q21.1 529
NEURONAL PAS DOMAIN PROTEIN 3; NPAS3 14q13 215
FORKHEAD BOX P1; FOXP1 3p14.1 173
ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 20; ZBTB20 3q13.2 156
RHO GTPase-ACTIVATING PROTEIN 15; ARHGAP15 147
KIAA0442 7q11.2 145
EARLY B-CELL FACTOR 3; EBF3 10q26.3 143
SRY-BOX 6; SOX6 11p15.3-p15.2 129
ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1; ANON1 1p 126
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3 1p36 126
BREAST CANCER, DUCTAL, 2; BRCD2 1p36 126
CATARACT, CONGENITAL, VOLKMANN TYPE; CCV 1pter-p36.13 126
CATARACT, POSTERIOR POLAR, 1; CTPP1 1pter-p36.1 126
CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER 1p36.3 126
DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8 1p36-p34 126
DYSTONIA 13, TORSION; DYT13 1p36.32-p36.13 126
GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B 1p36.2-p36.1 126
INFLAMMATORY BOWEL DISEASE 7; IBD7 1p36 126
LEBER CONGENITAL AMAUROSIS 9; LCA9 1p36 126
MELANOMA, CUTANEOUS MALIGNANT; CMM 1p36 126
MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1 1p34,1q25 126
PARKINSON DISEASE 10; PARK10 1p32 126
PSORIASIS SUSCEPTIBILITY 7; PSORS7 1p 126
SCHIZOPHRENIA 12 1p36.2 126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4 1p36 126
FORKHEAD BOX P2; FOXP2 7q31 125
ZINC FINGER HOMEOBOX 4; ZFHX4 8q21.12 124
ODZ, DROSOPHILA, HOMOLOG OF, 2; ODZ2 121
BASONUCLIN 2; BNC2 9p22.1 119
DACHSHUND, DROSOPHILA, HOMOLOG OF, 1; DACH1 13q22 119
ZINC FINGER E BOX-BINDING HOMEOBOX 2; ZEB2 2q22 116
EARLY B-CELL FACTOR; EBF 5q34 114
WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX 16q23.3-q24.1 114
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2 17p13 110
CATARACT, ANTERIOR POLAR, 2; CTAA2 17p13 110
CEREBELLAR HYPOPLASIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION; CHMRQ2 17p 110
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR; CACD 17p 110
MYASTHENIA, FAMILIAL INFANTILE, 1 17p13 110
RETINAL CONE DYSTROPHY 2 17p 110
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD 110
THYROID CARCINOMA, HURTHLE CELL 19p13.2-p13.1 110
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1 110
ZINC FINGER PROTEIN 521; ZNF521 18q11.2 110
HYPERLIPIDEMIA, COMBINED, 2 11p 107
NONCOMPACTION OF LEFT VENTRICULAR MYOCARDIUM, FAMILIAL ISOLATED, AUTOSOMAL DOMINANT 2 11p15 107
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7 11p15 107
SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3 11p15.5 107
WILMS TUMOR 2; WT2 107
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6 5p 102
MEIS1, MOUSE, HOMOLOG OF, 2; MEIS2 15q14-q25 102
POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1; KCNMA1 10q22.3 100
LIPOPOLYSACCHARIDE-RESPONSIVE, BEIGE-LIKE ANCHOR PROTEIN; LRBA 97
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 3; PBX3 9q33-q34 94
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA; PTPRD 9p24.3-p23 94
ZINC FINGER PROTEIN, MULTITYPE 2; ZFPM2 8q23 92
LYSINE-SPECIFIC DEMETHYLASE 5D; KDM5D Yq11 91
AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2 Xp22 90
AICARDI SYNDROME; AIC Xp22 90
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2 Xp22.2 90
DEAFNESS, X-LINKED 4; DFNX4 Xp22 90
EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX Xp22.3 90
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3 Xp22.2 90
FG SYNDROME 3; FGS3 Xp22.3 90
GOITER, MULTINODULAR 2; MNG2 Xp22 90
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS 90
HODGKIN DISEASE, X-LINKED PSEUDOAUTOSOMAL Xpter-p22.32 90
HYPERALDOSTERONISM, FAMILIAL, TYPE II 7p22 90
MENTAL RETARDATION, X-LINKED 2; MRX2 Xp22.3 90
N SYNDROME; NSX Xp22.3-p21.1 90
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR Xp22-p21 90
RETINITIS PIGMENTOSA 23; RP23 Xp22 90
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 Xp22 90
SPATIAL VISUALIZATION, APTITUDE FOR Xp22.33 90
WITTWER SYNDROME 90
CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI 6p 89
INFLAMMATORY BOWEL DISEASE 3; IBD3 6p21.3 89
LARSEN-LIKE SYNDROME 6p25 89
MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MRD 6p 89
USH2A GENE; USH2A 1q41 89
NEUREXIN 3; NRXN3 14q24.3-q31.1 87
AROMATIC ALPHA-KETO ACID REDUCTASE 12p 85
ATAXIA, SPASTIC, 1, AUTOSOMAL DOMINANT; SPAX1 12p13 85
BOWEN-CONRADI SYNDROME; BWCNS 12p13.3 85
EHLERS-DANLOS SYNDROME, TYPE VIII 12p13 85
TELOMERE LENGTH, MEAN LEUKOCYTE 14q23.2 85
CASTOR ZINC FINGER PROTEIN 1; CASZ1 1p36.22 84
NUCLEAR FACTOR I/A; NFIA 1p31.3-p31.2 83
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT, WITH THYROID DISEASE 2p 82
HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3 2p25-p24 82
POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3 82
PREECLAMPSIA/ECLAMPSIA 2; PEE2 2p25 82
A-KINASE ANCHOR PROTEIN 6; AKAP6 14q 79
DISABLED, DROSOPHILA, HOMOLOG OF, 1; DAB1 1p32-p31 76
ZINC FINGER HOMEOBOX 3; ZFHX3 16q22.3-q23.1 76
MACRO DOMAIN-CONTAINING 2; MACROD2 20p12 74
POLIOVIRUS RECEPTOR-LIKE 1; PVRL1 11q23-q24 74
ZINC FINGER PROTEIN 423; ZNF423 16q12 74
IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4; IGSF4 11q23.2 73
POLYMERASE, DNA, ALPHA; POLA Xp22.3-p21.1 72
DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD 1p22 71
THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX Chr.8 71
MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE AF4/FMR2 FAMILY, MEMBER 2, INCLUDED; AFF2, INCLUDED Xq28 70
RAN-BINDING PROTEIN 17; RANBP17 5q34 69
CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION; CADPS 3p21.1 68
TRANSCRIPTION FACTOR 7-LIKE 2; TCF7L2 10q25.3 67
CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS 3p 66
DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15 3q 66
DYSTROPHIN; DMD APO-DYSTROPHIN 1, INCLUDED Xp21.2 66
FRAGILE HISTIDINE TRIAD GENE; FHIT 3p14.2 66
INFLAMMATORY BOWEL DISEASE 9; IBD9 3p26 66
MOYAMOYA DISEASE 1; MYMY1 3p26-p24.2 66
PROSTATE CANCER, HEREDITARY, 5 3p26 66
SPINOCEREBELLAR ATAXIA 15; SCA15 SPINOCEREBELLAR ATAXIA 16, FORMERLY; SCA16, FORMERLY 3p26.1-p25.3 66
SPINOCEREBELLAR ATAXIA 29 3p26 66
STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5 3p26 66
TRANSCRIPTION FACTOR 4; TCF4 18q21.1 66
ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F0 COMPLEX, SUBUNIT E; ATP5I 65
MENTAL HEALTH WELLNESS 1 4p 65
MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1; MAPKAP1 65
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE 65
SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3 4p16-p15.2 65
MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5; MAP2K5 15q23 64
POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 2; POU6F2 7p14-p13 63
SMG6, C. ELEGANS, HOMOLOG OF; SMG6 17p13.3 62
NUCLEAR FACTOR I/B; NFIB 9p24.1 61
CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 1; CAMTA1 1p36 60
FAT MASS- AND OBESITY-ASSOCIATED GENE; FTO 16q12.2 60
KIN OF IRRE-LIKE 3; KIRREL3 11q24.2 60
PROTOCADHERIN 9; PCDH9 13q21.1 60
UBIQUITIN-SPECIFIC PROTEASE 6; USP6 17p13 60
ASTROTACTIN 2; ASTN2 9q33.1 58
NEUREXIN 1; NRXN1 2p16.3 58
B-CELL CLL/LYMPHOMA 11A; BCL11A 2p13 57
NEUROBEACHIN; NBEA FRAGILE SITE FRA13A, INCLUDED 13q13.2 57
ACETYL-CoA CARBOXYLASE-ALPHA; ACACA 17q21 56
SLIT, DROSOPHILA, HOMOLOG OF, 3; SLIT3 5q35 56
ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS 19p13.3-p13.2 55
BREAST CARCINOMA AMPLIFIED SEQUENCE 3; BCAS3 55
COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S 19pter-q13 55
DERMODISTORTIVE URTICARIA; DDU 55
EXOSTOSES, MULTIPLE, TYPE III; EXT3 19p 55
FEBRILE CONVULSIONS, FAMILIAL, 2; FEB2 19p13.3 55
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE 19pter-p13.1 55
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2 19p13.3 55
INFLAMMATORY BOWEL DISEASE 6; IBD6 19p13 55
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5 19p13 55
MUSASHI, DROSOPHILA, HOMOLOG OF, 2; MSI2 MSI2/HOXA9 FUSION GENE, INCLUDED 55
ODZ, DROSOPHILA, HOMOLOG OF, 1; ODZ1 55
PSORIASIS SUSCEPTIBILITY 6; PSORS6 19p13 55
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1; IS1 19p13.3 55
SPINOCEREBELLAR ATAXIA 26; SCA26 55
VACUOLAR NEUROMYOPATHY 19p13.3 55
MEIS1, MOUSE, HOMOLOG OF, 1; MEIS1 2p14-p13 54
OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML 11q25 54
SEC8, S. CEREVISIAE, HOMOLOG OF 7q31 54
V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 4; ERBB4 2q33.3-q34 54
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8 10p 53
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1 10p 53
CHROMOSOME 2 OPEN READING FRAME 34; C2ORF34 53
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1; PBX1 PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR PSEUDOGENE 1, INCLUDED; PBXP1, INCLUDED 1q23 53
GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING 1; GTDC1 2q22 52
ODZ, DROSOPHILA, HOMOLOG OF, 4; ODZ4 52
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, T; PTPRT 52
ALZHEIMER DISEASE 8 20p 51
AMYOTROPHIC LATERAL SCLEROSIS 7 20p13 51
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6 20pter-p11.2 51
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS 20p13 51
DERMATITIS, ATOPIC, 3; ATOD3 20p 51
EH DOMAIN-BINDING PROTEIN 1; EHBP1 2p15 51
ESTROGEN-RELATED RECEPTOR, GAMMA; ESRRG 1q41 51
LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; LSAMP 3q13.2-q21 51
SPINOCEREBELLAR ATAXIA 23; SCA23 20p13-p12.3 51
BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN; BTRC 10q24-q25 49
GLYPICAN 3; GPC3 Xq26 49
DIAMOND-BLACKFAN ANEMIA 2 8p23.3-p22 48
KERATOLYTIC WINTER ERYTHEMA 8p23-p22 48
MYOPIA 10; MYP10 8p23 48
ODZ, DROSOPHILA, HOMOLOG OF, 3; ODZ3 48
SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL OXODICARBOXYLATE CARRIER), MEMBER 21; SLC25A21 14q11.2 48
SRY-BOX 5; SOX5 12p12.1 48
WAARDENBURG SYNDROME, TYPE IIC 8p23 48
SRC FAMILY-ASSOCIATED PHOSPHOPROTEIN 1; SCAP1 Chr.17 47
PEROXISOME BIOGENESIS FACTOR 14; PEX14 1p36.2 46
SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 1; SATB1 3p23 46
TRANSDUCIN-LIKE ENHANCER OF SPLIT 4; TLE4 46
ZINC FINGER TRANSCRIPTION FACTOR TRPS1; TRPS1 8q24.12 46
HEPARAN SULFATE 6-O-SULFOTRANSFERASE 3; HS6ST3 13q32-q33 45
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HNRNPK 9q21.32-q21.33 45
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 3; CACNA2D3 3p21.1 44
CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 2; CUGBP2 10p13 44
GDP-MANNOSE 4,6-DEHYDRATASE; GMDS 6p25 44
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1 9p 44
MESOTHELIOMA, MALIGNANT 9p 44
METHYLGUANINE-DNA METHYLTRANSFERASE; MGMT 10q26 44
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, GAMMA; PTPRG 3p14.2 44
ANAPLASTIC LYMPHOMA KINASE; ALK ALK/EML4 FUSION GENE, INCLUDED 2p23 43
CHLORIDE CHANNEL 5; CLCN5 Xp11.22 43
DACHSHUND, DROSOPHILA, HOMOLOG OF, 2; DACH2 43
MINDBOMB, DROSOPHILA, HOMOLOG OF, 1; MIB1 43
CONTACTIN 4; CNTN4 3p26-p25 42
ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 1; ROBO1 3p12 42
TBC1 DOMAIN FAMILY, MEMBER 3; TBC1D3 17q12 42
CATENIN, ALPHA-2; CTNNA2 2p12-p11.1 41
CONTACTIN-ASSOCIATED PROTEIN-LIKE 2; CNTNAP2 7q35-q36 41
DIACYLGLYCEROL KINASE, BETA, 90-KD; DGKB 7p21.2 41
DISCS LARGE, DROSOPHILA, HOMOLOG OF, 2; DLG2 11q21 41
GTP-BINDING PROTEIN 9; GTPBP9 41
PR DOMAIN-CONTAINING PROTEIN 16; PRDM16 1p36.3 41
COH1 GENE; COH1 8q22-q23 40
RAD51, S. CEREVISIAE, HOMOLOG OF, B; RAD51L1 14q23.3-q24 40
ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 2; ROBO2 3p12.3 40
SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2 2q33 40
TBC1 DOMAIN FAMILY, MEMBER 3C; TBC1D3C 17q12 40
TEA DOMAIN FAMILY MEMBER 1; TEAD1 11p15.2 40
B-CELL CLL/LYMPHOMA 11B; BCL11B 14q32.1 39
CADHERIN 4; CDH4 20q13.3 39
FIDGETIN; FIGN 39
GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 3; GRIA3 Xq25-q26 39
NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3 9q22 39
PLEXIN A2; PLXNA2 1q32.2 39
SORCS RECEPTOR 3; SORCS3 10q23.3 39
TBC1 DOMAIN FAMILY, MEMBER 3B; TBC1D3B 17q12 39
BRUNO-LIKE 4; BRUNOL4 18q12 38
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT; CACNA1D 3p14.3 38
DOWN SYNDROME CELL ADHESION MOLECULE-LIKE 1; DSCAML1 11q23 38
EPHRIN RECEPTOR EphB1; EPHB1 3q21-q23 38
NUCLEAR FACTOR I/X; NFIX 19p13.3 38
PKHD1 GENE; PKHD1 6p21.1-p12 38
ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 16; ZBTB16 11q23.1 38
GLYPICAN 6; GPC6 13q32 37
CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1 17q11.2-q12 36
PBX/KNOTTED 1 HOMEOBOX 2; PKNOX2 11q24-q25 36
AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5B; ARID5B 10q21.2 35
BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 3; BAI3 6q12 35
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 2; CACNA2D2 3p21.3 35
CITRATE LYASE BETA-LIKE; CLYBL 13q32 35
EARLY B-CELL FACTOR 2; EBF2 8p21.2 35
EBNA2 COACTIVATOR p100 7q31.3 35
ELONGATION PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; ELP4 11p13 35
GLI-KRUPPEL FAMILY MEMBER 3; GLI3 7p13 35
GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2; GRIK2 6q21 35
PLEXIN A4; PLXNA4 7q32.3 35
ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1 16p13 34
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5 16p13 34
CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1 16pter-p13 34
CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1; CYP7B1 8q21.3 34
DELETED IN LYMPHOCYTIC LEUKEMIA, 2; DLEU2 13q14 34
HISTONE DEACETYLASE 9; HDAC9 7p21-p15 34
INFLAMMATORY BOWEL DISEASE 8; IBD8 16p 34
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1B; LRP1B 34
MICROHYDRANENCEPHALY; MHAC 16p13.3-p12.1 34
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1 16p13.3 34
MYOCLONIC EPILEPSY, INFANTILE 16p13 34
NEUROLIGIN 1; NLGN1 3q26.3 34
NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2; NR2C2 3p25 34
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2 16p13-p12 34
CADHERIN 13; CDH13 16q24.2-q24.3 33
EPHRIN A5; EFNA5 33
IQ MOTIF-CONTAINING PROTEIN H: IQCH 15q22.31 33
LATROPHILIN HOMOLOG 1; LPHH1 1p31.1 33
NHS GENE; NHS Xp22.13 33
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2; PTPRN2 7q36 33
CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 1; CBFA2T1 8q22 32
CUT-LIKE 1; CUTL1 7q22 32
DYNAMIN 3; DNM3 32
GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8 7q31.3-q32.1 32
PROPIONYL-CoA CARBOXYLASE, ALPHA SUBUNIT; PCCA 13q32 32
DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 1; DYNC1I1 7q21.3-q22.1 31
FAS-ASSOCIATED FACTOR 1; FAF1 31
GROWTH ARREST-SPECIFIC 5; GAS5 1q23.3 31
INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R 15q25-q26 31
NEUREGULIN 3; NRG3 10q22 31
NEURON NAVIGATOR 2; NAV2 11p15.1 31
NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3; NTRK3 15q25 31
POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2 7q31 31
SET-BINDING PROTEIN 1; SETBP1 18q21.1 31
TITIN; TTN 2q31 31
TRANSCRIPTION FACTOR 12; TCF12 15q21 31
CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1; CDKAL1 6p22.3 30
CUT-LIKE 2; CUTL2 30
DYNAMIN 1; DNM1 9q34 30
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A 16p13 30
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14 17q21 30
TENASCIN R; TNR 1q24 30
TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3 30
UNC5, C. ELEGANS, HOMOLOG OF, C; UNC5C 4q21-q23 30
ADENOSINE KINASE; ADK 10q11-q24 29
BTB AND CNC HOMOLOGY 2; BACH2 6q15 29
INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 2; IL1RAPL2 Xq22 29
MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2; MAGI2 7q21 29
PAIRED BOX GENE 3; PAX3 2q35 29
RE REPEATS-ENCODING GENE; RERE 1p36.2-p36.1 29
SKAP55-RELATED PROTEIN 7p21-p15 29
V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 3; AKT3 1q44 29
ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1 5q14.1 28
AF4/FMR2 FAMILY, MEMBER 3; AFF3 2q11.2-q12 28
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G 17q22 28
GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3 9p24.3-p23 28
HOMEODOMAIN-INTERACTING PROTEIN KINASE 2; HIPK2 7q33-q34 28
IMP DEHYDROGENASE 1; IMPDH1 7q31.3-q32 28
LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LPP 3q28 28
MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 1; MAGI1 3p14.1 28
PARKIN; PARK2 6q25.2-q27 28
SEMAPHORIN 5A; SEMA5A 5p15.2 28
SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A 12q13 28
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1E SUBUNIT; CACNA1E 1q25-q31 27
CATENIN, ALPHA-3; CTNNA3 10q21 27
CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 1; CNOT1 16q21 27
CENTLEIN; CNTLN 9p22.2 27
INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 1; IL1RAPL1 Xp22.1-p21.3 27
KALIRIN; KALRN HUNTINGTIN-ASSOCIATED PROTEIN-INTERACTING PROTEIN, INCLUDED; HAPIP, INCLUDED 27
NEUREXOPHILIN 1; NXPH1 27
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA; PPARGC1A 4p15.1 27
PRECURSOR mRNA-PROCESSING FACTOR 8, S. CEREVISIAE, HOMOLOG OF; PRPF8 17p13.3 27
RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1; ROR1 1p32-p31 27
REELIN; RELN 7q22 27
RNA-BINDING MOTIF PROTEIN 9; RBM9 22q13.1 27
SLIT, DROSOPHILA, HOMOLOG OF, 2; SLIT2 4p15.2 27
ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 1B; ANKS1B 12q23.1 26
BTB/POZ DOMAIN-CONTAINING PROTEIN 9; BTBD9 6p21 26
CELL ADHESION MOLECULE, NEURAL, 1; NCAM1 11q23.1 26
DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 2; DIAPH2 Xq22 26
EPHRIN RECEPTOR EphA7; EPHA7 26
MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE C; MEF2C 5q14 26
NUCLEAR TRANSCRIPTION FACTOR Y, GAMMA; NFYC 1p32 26
PAIRED BOX GENE 2; PAX2 10q24.3-q25.1 26
POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3 1p13.3-p13.2 26
SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA SUBUNIT; SCN2A 2q23-q24.3 26
SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1 14q24.1 26
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6; ADAMTS6 5q12 25
CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR 2q33 25
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7 8q12.1 25
CHROMOSOME 7 OPEN READING FRAME 10; C7ORF10 7p14 25
CUB AND SUSHI MULTIPLE DOMAINS 3; CSMD3 8q23.3 25
HISTONE DEACETYLASE 8; HDAC8 Xq13 25
La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 7; LARP7 4q25 25
NETRIN G1; NTNG1 1p13.3 25
PAIRED BOX GENE 6; PAX6 11p13 25
DYNAMIN 2; DNM2 19p13.2 24
ETS VARIANT GENE 6; ETV6 12p13 24
HECT, UBA, AND WWE DOMAINS-CONTAINING PROTEIN 1; HUWE1 Xp11.2 24
INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 40-KD; INPP5A 10q26.3 24
LIM HOMEOBOX TRANSCRIPTION FACTOR 1, BETA; LMX1B 9q34.1 24
MYOSIN IIIB; MYO3B 2q31.1-q31.2 24
NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1; NR6A1 9q33-q34.1 24
PATCHED, DROSOPHILA, HOMOLOG OF, 1; PTCH1 9q22.3 24
PFTAIRE PROTEIN KINASE 1; PFTK1 7q21.13 24
PROSPERO-RELATED HOMEOBOX 1; PROX1 1q32.2-q32.3 24
PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14 2q24.2 24
RETINOIC ACID RECEPTOR, ALPHA; RARA 17q21.1 24
RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 3; RBMS3 3p24-p23 24
RPGRIP1-LIKE; RPGRIP1L 16q12.2 24
SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4; SLC4A4 4q21 24
SUPPRESSOR OF TY 3, S. CEREVISIAE, HOMOLOG OF; SUPT3H 24
UBIQUITIN-SPECIFIC PROTEASE 9, X CHROMOSOME; USP9X Xp11.4 24
ZINC FINGER PROTEIN 385B; ZNF385B 2q31.2-q31.3 24
3-@PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1; PDPK1 16p13.3 23
ASTROTACTIN 1; ASTN1 1q25 23
CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; CADPS2 7q31.3 23
CARBONIC ANHYDRASE X; CA10 Chr.17 23
DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5; DNAJC5 23
EPHRIN RECEPTOR EphB2; EPHB2 1p36.1-p35 23
GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3; GRIK3 1p34-p33 23
JUXTAPOSED WITH ANOTHER ZINC FINGER GENE 1; JAZF1 7p15 23
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1 12q13.1-q13.3 23
MASTERMIND-LIKE 3; MAML3 4q28.3 23
MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 7; MCM7 7q21.3-q22.1 23
NEVER IN MITOSIS GENE A-RELATED KINASE 7; NEK7 1q31.3 23
WW DOMAIN-CONTAINING PROTEIN 2; WWP2 16q21 23
ANKYRIN 2; ANK2 4q25-q27 22
BRAIN-DERIVED NEUROTROPHIC FACTOR, OPPOSITE STRAND; BDNFOS 22
EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 2; ELAVL2 9p21 22
EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2 3q28 22
FORKHEAD BOX N3; FOXN3 14q24.3-q31 22
FORMIN-LIKE; FMNL 17q21 22
FORMIN; FMN 15q13-q14 22
GLYPICAN 5; GPC5 13q32 22
GTPase-ACTIVATING RAP/RAN-GAP DOMAIN-LIKE 1; GARNL1 22
LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC 2p21-p16 22
MIRROR-IMAGE POLYDACTYLY GENE 1; MIPOL1 14q13 22
PAIRED BOX GENE 7; PAX7 1p36.2-p36.12 22
PARTITIONING-DEFECTIVE PROTEIN 3, C. ELEGANS, HOMOLOG OF; PARD3 10p11.21 22
PHOSPHODIESTERASE 4B, cAMP-SPECIFIC; PDE4B 1p31 22
PHOSPHODIESTERASE 4D, cAMP-SPECIFIC; PDE4D 5q12 22
RAR-RELATED ORPHAN RECEPTOR A; RORA 15q21-q22 22
RYANODINE RECEPTOR 2; RYR2 1q42.1-q43 22
SYNAPSIN III; SYN3 22q12.3 22
THYROID HORMONE RECEPTOR, ALPHA-1; THRA 17q11.2 22
CARTILAGE ACIDIC PROTEIN 1; CRTAC1 21
CATENIN, DELTA-2; CTNND2 5p15.2 21
DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46 18p11.32-p11.31 21
DELETED IN COLORECTAL CARCINOMA; DCC 18q21.3 21
DYSTONIA 15, MYOCLONIC; DYT15 18p11 21
DYSTONIA 7, TORSION; DYT7 18p 21
EPHRIN RECEPTOR EphA4; EPHA4 21
FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 3; FAT3 11q14.3-q21 21
GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2 9q22.1 21
GOLGI-SPECIFIC BREFELDIN-A RESISTANCE FACTOR 1; GBF1 10q24 21
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2; HIVEP2 6q23-q24 21
HYPOTRICHOSIS SIMPLEX 18p11.32-p11.23 21
INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1 3p26-p25 21
MAJOR AFFECTIVE DISORDER 1; MAFD1 18p 21
MITOTIC ARREST-DEFICIENT 1, YEAST, HOMOLOG-LIKE 1; MAD1L1 7p22 21
MUSCLEBLIND-LIKE PROTEIN 2; MBNL2 21
PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I; PRKG1 10q11.2 21
PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA; PPP2R2B 5q31-q33 21
PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1 6q12-q13 21
PROTOCADHERIN 19; PCDH19 Xq13.3 21
PROTOCADHERIN 7; PCDH7 4p15 21
RETINOBLASTOMA-ASSOCIATED FACTOR 600 1p36.13 21
RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1 21q22.3 21
SCHIZOPHRENIA 8; SCZD8 18p 21
SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, ALPHA SUBUNIT; SCN3A 2q24 21
SYNAPTOTAGMIN 7; SYT7 11q13 21
SYNTAXIN 8; STX8 17p12 21
XYLOSYLTRANSFERASE 1; XYLT1 16p13.1 21
ZINC FINGER AND RING FINGER PROTEIN 3; ZNRF3 22q12.1 21
5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C Xq24 20
BCH MOTIF-CONTAINING MOLECULE AT THE C-TERMINAL REGION 1 9p13 20
D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 3; DPF3 14q24.3-q31.1 20
EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 4; ELAVL4 1p34 20
F-BOX AND WD40 DOMAIN PROTEIN 4; FBXW4 10q24 20
GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 1; GRID1 10q22 20
GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 2; GRID2 4q22 20
GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1; GRIK1 21q22 20
GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 6; GOLGA6 20
GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2 11q13.4-q13.5 20
HISTONE ACETYLTRANSFERASE MYST4; MYST4 10q22 20
LIM DOMAIN ONLY 4; LMO4 1p22.3 20
MUSCLEBLIND-LIKE PROTEIN 1; MBNL1 3q25 20
PEPTIDE METHIONINE SULFOXIDE REDUCTASE; MSRA 20
POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG 10q11.23 20
PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-2; PRKAG2 7q36 20
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, KAPPA; PTPRK 6q22.2-q22.3 20
RUNT-RELATED TRANSCRIPTION FACTOR 2; RUNX2 6p21 20
SELENOPROTEIN TRANSLATION FACTOR SELB 20
SIDEKICK, DROSOPHILA, HOMOLOG OF, 1; SDK1 20
SINGLE-STRANDED DNA-BINDING PROTEIN 3; SSBP3 1p31.3 20
SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 3; SLC24A3 20p13 20
STROMAL ANTIGEN 2; STAG2 20
SUPPRESSOR OF TUMORIGENICITY 7; ST7 7q31.1 20
TALIN 2; TLN2 15q15-q21 20
V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG; ERG 21q22.3 20
ACTIVATING MOLECULE IN BECLIN 1-REGULATED AUTOPHAGY 19
APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF 17q11.2-q12 19
ARIADNE, DROSOPHILA, HOMOLOG OF, 2; ARIH2 3p21 19
AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 2; ARID2 19
ATAXIN 1; ATXN1 6p23 19
BRAIN CYTOPLASMIC RNA 1; BCYRN1 19
CADHERIN 23; CDH23 10q21-q22 19
CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE HOMOLOG; CBL 11q23.3 19
CHROMOBOX HOMOLOG 5; CBX5 19
CYTOPLASMIC FMRP-INTERACTING PROTEIN 2; CYFIP2 5q33.3 19
DOWN SYNDROME CELL ADHESION MOLECULE; DSCAM 21q22.2-q22.3 19
ECTO-NOX DISULFIDE-THIOL EXCHANGER 2; ENOX2 Xq25-q26.2 19
FETAL ALZHEIMER ANTIGEN; FALZ 17q24 19
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B; GRIN2B 12p12 19
GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2-LIKE, Y-LINKED; GOLGA2LY 19
HECT DOMAIN AND RCC1-LIKE DOMAIN 1; HERC1 19
HIGH MOBILITY GROUP AT-HOOK 2; HMGA2 12q14.3 19
HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4 15q24-q25 19
MIDLINE 1; MID1 Xp22 19
MYC-BINDING PROTEIN 2; MYCBP2 19
NEUROFIBROMIN 2; NF2 22q12.2 19
NIPPED-B-LIKE; NIPBL 5p13.1 19
POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1; POU2F1 1q22-q23 19
PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP3CA 4q24-q25 19
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, MU; PTPRM 18p11.2 19
RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4 19
SARCOGLYCAN, ZETA; SGCZ 19
SEC16, S. CEREVISIAE, HOMOLOG OF, A; SEC16A 9q34.3 19
SPERMATOGENESIS-ASSOCIATED PROTEIN 17; SPATA17 1q41 19
TRAF2- AND NCK-INTERACTING KINASE; TNIK 3q26.2-q26.3 19
VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, D; VPS13D 19
ALPORT SYNDROME, MENTAL RETARDATION, MIDFACE HYPOPLASIA, AND ELLIPTOCYTOSIS CHROMOSOMAL REGION GENE 1; AMMECR1 Xq22.3 18
ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 11; ANKRD11 18
BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2B; BAZ2B 2q23-q24 18
CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE; CASK Xp11.4 18
CATENIN, BETA-LIKE, 1; CTNNBL1 20q11.2-q12 18
CHROMOSOME 11 OPEN READING FRAME 8; C11ORF8 11p14-p13 18
CYSTEINE-RICH MOTOR NEURON PROTEIN 1; CRIM1 2p22-p21 18
CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3; CPEB3 10q23.3 18
DAB2-INTERACTING PROTEIN; DAB2IP 18
DEDICATOR OF CYTOKINESIS 1; DOCK1 10q26.13-q26.3 18
DEDICATOR OF CYTOKINESIS 9; DOCK9 13q32.3 18
DELETED IN LIVER CANCER 1; DLC1 8p22-p21.3 18
ECTO-NOX DISULFIDE-THIOL EXCHANGER 1; ENOX1 13q14.11 18
ENGULFMENT AND CELL MOTILITY GENE 1; ELMO1 7p14 18
EPHRIN RECEPTOR EphA6; EPHA6 18
EXOCYST COMPLEX COMPONENT 6B; EXOC6B 2p13.2 18
EXPORTIN 1; XPO1 2p16 18
F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17; FBXL17 5q21.3 18
FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN 1; FRAP1 1p36.2 18
GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2; GRIA2 4q32-q33 18
GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2; GOLGA2 18
HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2; HS6ST2 Xq26.2 18
INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; IMMP2L 7q31 18
JUMONJI, AT-RICH INTERACTIVE DOMAIN 2; JARID2 6p24-p23 18
LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6C; LRRN6C 9p21.2-p21.1 18
LIM DOMAIN ONLY 1; LMO1 11p15 18
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 3; MLLT3 9p22 18
NEUROPILIN 1; NRP1 10p12 18
NEUROPILIN 2; NRP2 2q34 18
NOTCH, DROSOPHILA, HOMOLOG OF, 2; NOTCH2 1p13-p11 18
NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2; NR5A2 1q32.1 18
POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6; KCNJ6 21q22.1 18
PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 2; RIMS2 Chr.8 18
RAR-RELATED ORPHAN RECEPTOR B; RORB 9q22 18
RIBOSOMAL PROTEIN L3; RPL3 22q 18
RYANODINE RECEPTOR 3; RYR3 15q14-q15 18
SARCOGLYCAN, DELTA; SGCD 5q33 18
SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13; SLC25A13 7q21.3 18
ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3; ST6GALNAC3 18
TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TRRAP 7q21.2-q22.1 18
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 3; TRPM3 9q21.12 18
TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2 18
UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON X CHROMOSOME; UTX Xp11.2 18
ZINC FINGER AND HOMEODOMAIN PROTEIN 3; ZHX3 20q12 18
ZINC FINGER MIZ-DOMAIN CONTAINING 1; ZMIZ1 10q22.1-q22.3 18
3-@HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH 17
ADAMTS-LIKE PROTEIN 1; ADAMTSL1 9p22.1-p21.2 17
ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-1 SUBUNIT; AP1G1 16q23 17
ADENYLATE CYCLASE 3; ADCY3 2p24-p22 17
ANKYRIN 3; ANK3 10q21 17
AUTOPHAGY 10, S. CEREVISIAE, HOMOLOG OF; ATG10 5q14.2 17
BCL6 COREPRESSOR; BCOR Xp11.4 17
BRAF35/HDAC COMPLEX, 80-KD SUBUNIT 11p11.2 17
BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE 17
CALNEURON 1; CALN1 17
DEAFNESS LOCUS-ASSOCIATED PUTATIVE GUANINE NUCLEOTIDE EXCHANGE FACTOR 11p14 17
DIACYLGLYCEROL KINASE, IOTA, 130-KD; DGKI 7q32.3-q33 17
DIPEPTIDYL PEPTIDASE VI; DPP6 7q36.2 17
DISCS LARGE, DROSOPHILA, HOMOLOG OF, 5; DLG5 10q23 17
F-BOX AND WD40 DOMAIN PROTEIN 11; FBXW11 5q35.1 17
FLJ10986 17
GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3; GABRA3 Xq28 17
HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE; HSPG2 1p36.1 17
HOMEOBOX B3; HOXB3 17q21-q22 17
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 3; HIVEP3 1p34 17
LIM DOMAIN ONLY 3; LMO3 12p13 17
MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 2; MDGA2 14q21 17
METAL-REGULATORY TRANSCRIPTION FACTOR 1; MTF1 1p33 17
MYOSIN, HEAVY CHAIN 7B, CARDIAC MUSCLE, BETA; MYH7B 20q11.22 17
NEOGENIN; NEO1 15q22.3-q23 17
PARATHYROID HORMONE-RESPONSIVE B1 GENE 7p14 17
PREGNANCY-ASSOCIATED PLASMA PROTEIN A; PAPPA 9q33.1 17
PROTEIN KINASE C, ALPHA; PRKCA 17q22-q23.2 17
PROTEIN KINASE D1; PRKD1 14q11 17
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F; PTPRF 1p32 17
PUMILIO, DROSOPHILA, HOMOLOG OF, 1; PUM1 1p35.2 17
SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 7; SLC10A7 17
SORCS RECEPTOR 1; SORCS1 10q23.3 17
SPLICING FACTOR 3B, SUBUNIT 1; SF3B1 2q33.1 17
TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2 17
TUBBY, MOUSE, HOMOLOG OF; TUB 17
UBIQUITIN-SPECIFIC PROTEASE 24; USP24 1p32.3 17
V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC 8q24.12-q24.13 17
ADENOSINE DEAMINASE, RNA-SPECIFIC, B2; ADARB2 10p15 16
ATPase, CLASS I, TYPE 8A, MEMBER 1; ATP8A1 16
ATTRACTIN-LIKE 1; ATRNL1 10q26 16
C-TYPE LECTIN DOMAIN FAMILY 16, MEMBER A; CLEC16A 16
CALSYNTENIN 2; CLSTN2 16
CLIP-ASSOCIATED PROTEIN 1; CLASP1 2q14 16
CYTOPLASMIC FMRP-INTERACTING PROTEIN 1; CYFIP1 15q11 16
DEDICATOR OF CYTOKINESIS 4 7q31 16
DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A 21q22.1 16
DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1; DYNC1H1 14q32 16
E3 UBIQUITIN PROTEIN LIGASE, HECT DOMAIN-CONTAINING, 1; EDD1 8q22.3 16
ETS VARIANT GENE 1; ETV1 7p22 16
EXOSTOSIN 1; EXT1 8q24.11-q24.13 16
EYES ABSENT 4; EYA4 6q23 16
FIBROBLAST GROWTH FACTOR 14; FGF14 13q34 16
GLI-KRUPPEL FAMILY MEMBER 2; GLI2 2q14 16
GLIS FAMILY ZINC FINGER PROTEIN 1; GLIS1 16
GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1 5q33 16
GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 4; GRIK4 11q22.3 16
HEDGEHOG-INTERACTING PROTEIN; HHIP 4q28-q32 16
HYPERMETHYLATED IN CANCER 2; HIC2 22q11.2 16
IKAROS FAMILY ZINC FINGER 2; IKZF2 16
KRUPPEL-LIKE FACTOR 12; KLF12 13q22 16
KRUPPEL-LIKE FACTOR 13; KLF13 Chr.15 16
MAP KINASE-ACTIVATING DEATH DOMAIN; MADD 11p11.2 16
MEDIATOR COMPLEX SUBUNIT 27; MED27 9q34 16
MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF 3p14.1-p12.3 16
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 3; SMAD3 15q21-q22 16
MYELIN TRANSCRIPTION FACTOR 1-LIKE; MYT1L 2p24 16
N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 2 3q26.3 16
Na+/K+ TRANSPORTING ATPase-INTERACTING 2; NKAIN2 6q21 16
NEUREXIN 2; NRXN2 11q13 16
NEUROFIBROMATOSIS, TYPE I; NF1 17q11.2 16
NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2 9q22.1 16
NUCLEAR FACTOR OF ACTIVATED T CELLS 5; NFAT5 16
O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; OGT Xq13 16
PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 3; PDZRN3 3p13 16
PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; FARS2 6p25.1 16
PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, BETA; PPP2R1B 11q22-q24 16
PURINE-RICH ELEMENT-BINDING PROTEIN B; PURB 16
QUAKING, MOUSE, HOMOLOG OF; QKI 16
REGULATORY FACTOR X, 3; RFX3 16
RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6 Xp22.3 16
RYANODINE RECEPTOR 1; RYR1 19q13.1 16
SERINE/THREONINE PROTEIN KINASE 3; STK3 16
SH3-DOMAIN GRB2-LIKE (ENDOPHILIN)-INTERACTING PROTEIN 1; SGIP1 1p31.3 16
SPECTRIN, ALPHA, NONERYTHROCYTIC 1; SPTAN1 9q33-q34 16
SPERM-ASSOCIATED ANTIGEN 16; SPAG16 2q34 16
THYROTROPIN-RELEASING HORMONE-DEGRADING ECTOENZYME 12q15-q21 16
TRINUCLEOTIDE REPEAT-CONTAINING GENE 6B; TNRC6B 22q13.1 16
A-KINASE ANCHOR PROTEIN 13; AKAP13 15q24-q25 15
ACTININ, ALPHA-1; ACTN1 14q22-q24 15
ACTIVE BCR-RELATED GENE; ABR 17p13.3 15
ALPHA-KINASE 1; ALPK1 4q25 15
ASH1, DROSOPHILA, HOMOLOG OF 15
AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 1A; ARID1A 1p36.1-p35 15
CADHERIN 12; CDH12 5p14-p13 15
CADHERIN 6; CDH6 5p15.1-p14 15
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-4 SUBUNIT; CACNB4 EPISODIC ATAXIA, TYPE 5, INCLUDED; EA5, INCLUDED 2q22-q23 15
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-GAMMA; CAMK2G 10q22 15
CATENIN, ALPHA-1; CTNNA1 5q31 15
CTD SMALL PHOSPHATASE 2; CTDSP2 15
CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4; CPEB4 5q21 15
DEAD/H BOX 3, X-LINKED; DDX3X Xp11.3-p11.23 15
DOUBLECORTIN- AND CALMODULIN KINASE-LIKE 1; DCAMKL1 13q13 15
DYSTROBREVIN, ALPHA; DTNA 18q12.1-q12.2 15
EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2 11p15 15
FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER A; FAM120A 9q22.31 15
FRIEND LEUKEMIA VIRUS INTEGRATION 1; FLI1 11q24 15
GDNF FAMILY RECEPTOR ALPHA-1; GFRA1 10q26 15
GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4; GRIA4 11q22-q23 15
GLYPICAN 4; GPC4 Xq26 15
INSULIN-LIKE GROWTH FACTOR II; IGF2 11p15.5 15
KARYOPHERIN ALPHA-4; KPNA4 11q22 15
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C; LRRC4C 11p12 15
LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL 4p15.3 15
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA GENE; MLL 11q23 15
NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15 1q21.1 15
NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1 1p36.2 15
NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2 4q31.1 15
PHOSPHODIESTERASE 2A, cGMP-STIMULATED; PDE2A 15
PHOSPHODIESTERASE 7B, cAMP-SPECIFIC, HIGH-AFFINITY; PDE7B 15
PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 6; PLEKHA6 1q32.1 15
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2; KCNB2 Chr.8 15
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2 7q35-q36 15
POTASSIUM CHANNEL-INTERACTING PROTEIN 1; KCNIP1 15
PROTEASE, SERINE, 1; PRSS1 7q35 15
PROTEIN KINASE C, EPSILON; PRKCE 2p21 15
RAS-RELATED PROTEIN RAP1B; RAP1B 12q14 15
RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1 15
RETINOIC ACID RECEPTOR, BETA; RARB 3p24 15
RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26 5q31 15
RIBOSOMAL PROTEIN L4; RPL4 15q 15
SEMAPHORIN 6A; SEMA6A 15
SH3-DOMAIN KINASE-BINDING PROTEIN 1; SH3KBP1 Xp22.1-p21.3 15
SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 9; SLC9A9 3q24 15
SON DNA-BINDING PROTEIN; SON 21q22.1-q22.2 15
STROMAL ANTIGEN 1; STAG1 15
TRANSFERRIN RECEPTOR; TFRC 3q29 15
WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 2; WASF2 1p36.11-p34.3 15
ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7B; ZBTB7B 15
ADENYLATE CYCLASE 5; ADCY5 3q13.2-q21 14
AF4/FMR2 FAMILY, MEMBER 4; AFF4 5q31 14
ATR-X GENE; ATRX Xq13 14
BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF 11p13 14
CADHERIN 11; CDH11 16q21-q22.1 14
CASEIN KINASE I, GAMMA-1; CSNK1G1 15q22.1-q22.31 14
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE; CHD1L 1q21 14
COLLAGEN, TYPE XII, ALPHA-1; COL12A1 14
EPHRIN B1; EFNB1 Xq12 14
ESTROGEN RECEPTOR 1; ESR1 6q25.1 14
EYES ABSENT 1; EYA1 8q13.3 14
F-BOX AND WD40 DOMAIN PROTEIN 7; FBXW7 4q31.3 14
FIBRILLIN 1; FBN1 15q21.1 14
FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 1; FREM1 9p22.3 14
GEPHYRIN; GPHN 14q24 14
GLUTAMATE RECEPTOR, METABOTROPIC, 7; GRM7 3p26.1-p25.2 14
GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2; GPD2 2q24.1 14
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O; GNAO1 16q13 14
HEAT-SHOCK 70-KD PROTEIN 1A; HSPA1A 6p21.3 14
HECT DOMAIN AND RCC1-LIKE DOMAIN 2; HERC2 15q13.1 14
KIAA2022 14
LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1; LTBP1 2p12-q22 14
LIM DOMAIN-BINDING 2; LDB2 4p15 14
MACRO DOMAIN-CONTAINING 1; MACROD1 14
MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 3; MLL3 7q36 14
MYOSIN ID; MYO1D 17q11-q12 14
MYOSIN XVIIIA; MYO18A 14
MYOSIN, HEAVY CHAIN 10, NONMUSCLE; MYH10 17p13 14
NEURON NAVIGATOR 3; NAV3 12q21.1 14
NIK- AND IKBKB-BINDING PROTEIN 8q24.3 14
NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX DOMAIN PROTEIN 1; NSD1 5q35 14
NUCLEOLIN; NCL 2q12-qter 14
PAIRED BOX GENE 5; PAX5 9p13 14
PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 4; PDZRN4 12q12 14
PHOSPHATASE AND ACTIN REGULATOR 1; PHACTR1 14
PHOSPHODIESTERASE 11A; PDE11A 2q31.2 14
PHOSPHOLIPASE C, BETA-4; PLCB4 20p12 14
PROTEASOME SUBUNIT, BETA-TYPE, 7; PSMB7 9q34.11-q34.12 14
PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2; PCBD2 5q31.2 14
RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; RAPGEF2 14
RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 3; RPS6KA3 Xp22.2-p22.1 14
RIBOSOMAL PROTEIN S8; RPS8 1p34.1-p32 14
SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER 10; SLC4A10 EPILEPSY, COMPLEX PARTIAL, WITH MENTAL RETARDATION AND COGNITIVE DECLINE, INCLUDED 2q23-q24 14
STROMAL INTERACTION MOLECULE 1; STIM1 11p15.5 14
SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25 20p11.2 14
SYNTAXIN 17; STX17 9q31 14
TENSIN 1; TNS1 2q35-q36 14
THYROID HORMONE RECEPTOR, BETA; THRB 3p24.3 14
TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A 6p24 14
TRANSDUCIN-LIKE ENHANCER OF SPLIT 1; TLE1 9q21.3 14
TRANSPORTIN 2; TNPO2 19p13.13 14
TUMOR PROTEIN p63; TP63 3q27 14
VAC14, S. CEREVISIAE, HOMOLOG OF; VAC14 16q22.1 14
VACUOLAR PROTEIN SORTING 41, YEAST, HOMOLOG OF; VPS41 7p14.1 14
ZINC FINGER PROTEIN 238; ZNF238 1q44 14
ANKYRIN REPEATS- AND FYVE DOMAIN-CONTAINING PROTEIN 1; ANKFY1 13
B-CELL CLL/LYMPHOMA 9; BCL9 1q21 13
BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A; BAZ2A 12q24.3-qter 13
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; CACNB2 10p12 13
CATENIN, DELTA-1; CTNND1 11q11 13
CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 1; CCAR1 10q21.3 13
CHM GENE; CHM Xq21.2 13
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 3; CHD3 17p13 13
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 8; CHD8 14q11.2 13
CHROMOSOME 15 OPEN READING FRAME 2; C15ORF2 15q11-q13 13
COLLAGEN, TYPE I, ALPHA-2; COL1A2 7q22.1 13
CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 2; CPEB2 4q32-q33 13
DEDICATOR OF CYTOKINESIS 2; DOCK2 5q35.1 13
DICER, DROSOPHILA, HOMOLOG OF, 1; DICER1 14q31 13
DOUBLECORTIN; DCX Xq22.3-q23 13
DYSTONIN; DST 6p12-p11 13
ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5 1p22 13
ENDOTHELIN RECEPTOR, TYPE B; EDNRB 13q22 13
EPHRIN RECEPTOR EphA3; EPHA3 3p11.2 13
EUKARYOTIC TRANSLATION TERMINATION FACTOR 1; ETF1 5q31.1 13
EXPORTIN 4; XPO4 EXP4 13
EXPORTIN 7; XPO7 Chr.8 13
FRAS1 GENE; FRAS1 4q21 13
GROWTH FACTOR RECEPTOR-BOUND PROTEIN 14; GRB14 2q22-q24 13
GROWTH HORMONE RECEPTOR; GHR GROWTH HORMONE-BINDING PROTEIN, INCLUDED; GHBP, INCLUDED 5p13-p12 13
HOLOCARBOXYLASE SYNTHETASE; HLCS 21q22.1 13
IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 1; IQSEC1 13
JANUS KINASE 2; JAK2 MYELOPROLIFERATIVE DISORDER WITH ERYTHROCYTOSIS, INCLUDED 9p24 13
JUMONJI DOMAIN-CONTAINING PROTEIN 1C; JMJD1C 13
KINESIN-ASSOCIATED PROTEIN 3; KIFAP3 1q24.2 13
KRUPPEL-LIKE FACTOR 7; KLF7 2q32 13
MICROTUBULE-ASSOCIATED PROTEIN 1B; MAP1B 5q13 13
MITOGEN-ACTIVATED KINASE KINASE KINASE 1; MAP3K1 5q11.2 13
MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 5; MLL5 7q22 13
MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL; MYH8 17p13.1 13
NEMO-LIKE KINASE; NLK 13
NEUROONCOLOGIC VENTRAL ANTIGEN 1; NOVA1 14q 13
NUCLEAR PORE COMPLEX-INTERACTING PROTEIN; NPIP 16p13.1 13
NUCLEAR RESPIRATORY FACTOR 1; NRF1 7q32 13
PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 2; PITPNM2 13
PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM 11q14 13
PLEOMORPHIC ADENOMA GENE-LIKE 2; PLAGL2 13
POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1 11p15.5 13
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 1; KCNC1 11p15 13
PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1 12p13 13
REGULATORY FACTOR X, 4; RFX4 13
SET AND MYND DOMAIN-CONTAINING PROTEIN 3; SMYD3 13
SIL1, S. CEREVISIAE, HOMOLOG OF; SIL1 5q31 13
SODIUM LEAK CHANNEL, NONSELECTIVE; NALCN 13q32.3 13
SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 3A1; SLCO3A1 15q26 13
SPECTRIN, BETA, NONERYTHROCYTIC, 1; SPTBN1 2p21 13
SPERMATOGENESIS-ASSOCIATED PROTEIN 16; SPATA16 3q26.3 13
STRUCTURAL MAINTENANCE OF CHROMOSOMES 4; SMC4 3q26.1 13
T-CELL LYMPHOMA INVASION AND METASTASIS 1; TIAM1 21q22.1 13
THYROID HORMONE RECEPTOR INTERACTOR 12; TRIP12 2q36.3 13
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1; TRPM1 15q13-q14 13
TRIPARTITE MOTIF-CONTAINING PROTEIN 14; TRIM14 9q22-q31 13
TRIPLE FUNCTIONAL DOMAIN; TRIO 5p15.1-p14 13
UBIQUITIN-SPECIFIC PROTEASE 9, Y CHROMOSOME; USP9Y Yq11.2 13
UNC13, C. ELEGANS, HOMOLOG OF, B; UNC13B Chr.9 13
UV RADIATION RESISTANCE-ASSOCIATED GENE; UVRAG 11q13 13
WOLF-HIRSCHHORN SYNDROME CANDIDATE 1-LIKE 1; WHSC1L1 8p12 13
X-RAY RADIATION RESISTANCE-ASSOCIATED 1; XRRA1 11q13.3 13
ZINC FINGER PROTEIN 132; ZNF132 19q13.4 13
A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12; ADAM12 10q26.3 12
ACTIN, GAMMA-1; ACTG1 17q25.3 12
ANK, MOUSE, HOMOLOG OF; ANKH 5p15.2-p14.1 12
ARRESTIN DOMAIN-CONTAINING 3; ARRDC3 5q14.3 12
ARRESTIN, BETA, 1; ARRB1 11q13 12
AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4B; ARID4B 1q42.1-q43 12
ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4; ATP2B4 1q25-q32 12
B-CELL CLL/LYMPHOMA 2; BCL2 18q21.3 12
BCL2-LIKE 1; BCL2L1 12
BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IB; BMPR1B 4q23-q24 12
CADHERIN 8; CDH8 16q21-q22.1 12
CHOLINERGIC RECEPTOR, MUSCARINIC, 2; CHRM2 7q35-q36 12
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4; CHD4 12p13 12
CHROMOSOME 18 OPEN READING FRAME 1; C18ORF1 18p11.2 12
COLD-SHOCK DOMAIN-CONTAINING E1, RNA-BINDING; CSDE1 1p22 12
COLLAGEN, TYPE XXV, ALPHA-1; COL25A1 4q25 12
COPINE IV; CPNE4 12
CULLIN 3; CUL3 2q36 12
CYCLIN-DEPENDENT KINASE-LIKE 5; CDKL5 Xp22 12
CYSTEINE-RICH HYDROPHOBIC DOMAIN 2; CHIC2 4q11-q12 12
DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1; DAAM1 Chr.14 12
DYSFERLIN; DYSF 2p13.3-p13.1 12
ECTODYSPLASIN A; EDA Xq12-q13.1 12
EMX2 OPPOSITE STRAND; EMX2OS 10q26 12
EPHRIN B2; EFNB2 13q33 12
FIBRONECTIN DOMAIN III-CONTAINING PROTEIN 3B; FNDC3B 3q26 12
FILAMIN A-INTERACTING PROTEIN 1-LIKE; FILIP1L 3q12.1 12
FILAMIN A-INTERACTING PROTEIN 1; FILIP1 6q14.1 12
FORKHEAD BOX P4; FOXP4 12
GAMMA-AMINOBUTYRIC ACID RECEPTOR, EPSILON; GABRE Xq28 12
GLUTAMATE RECEPTOR, METABOTROPIC, 1; GRM1 6q24 12
GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3 7q21.1-q21.2 12
H1 HISTONE FAMILY, MEMBER T; H1FT 6p21.3 12
HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 4; HS3ST4 16p11.2 12
HISTONE DEACETYLASE 4; HDAC4 2q37.2 12
IgA CONSTANT HEAVY CHAIN 2; IGHA2 14q32.33 12
INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3; ITPR3 6pter-p21 12
JUMONJI DOMAIN-CONTAINING PROTEIN 2B; JMJD2B 19p13.3 12
KINESIN FAMILY MEMBER 1B; KIF1B 1p36.2 12
KINESIN FAMILY MEMBER 5C; KIF5C 2q23.1 12
LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 5; LRRN5 1q32.1 12
LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 6; LGR6 1q32 12
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16A; LRRC16A 6p22.2 12
MALIC ENZYME 3; ME3 11cen-q22.3 12
MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 3; MICAL3 22q11.21 12
MUTATED IN COLORECTAL CANCERS; MCC 5q21 12
MYOSIN LIGHT CHAIN KINASE; MYLK 3q21 12
MYOSIN, HEAVY CHAIN 15; MYH15 3q13.13 12
MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE; MYH4 17p13.1 12
MYOSIN, SKELETAL MUSCLE, HEAVY CHAIN 13; MYH13 17p13.1-p12 12
MYOSIN-BINDING PROTEIN C, SLOW TYPE; MYBPC1 Chr.12 12
NETRIN 1, MOUSE, HOMOLOG OF; NTN1 12
NEUREGULIN 1; NRG1 8p22-p11 12
NEUROFASCIN 12
NONHOMOLOGOUS END-JOINING FACTOR 1; NHEJ1 2q35 12
NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2; NR2F2 15q26.1-q26.2 12
PANTOTHENATE KINASE 1 10q23 12
PHOSPHATIDYLINOSITOL-3-PHOSPHATE 5-KINASE, TYPE III; PIP5K3 2q35 12
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT; PAFAH1B1 17p13.3 12
PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 5; PLEKHA5 12p12 12
PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-PRIME; PPP2R4 9q34 12
RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 1; RGPD1 2p11.2 12
RIBONUCLEASE P, RNA COMPONENT H1; RPPH1 12
RIBOSOMAL PROTEIN L17; RPL17 18q 12
RIBOSOMAL PROTEIN L27a; RPL27A 11p15 12
RIBOSOMAL PROTEIN L7a; RPL7A 9q34 12
RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 2; RPS6KA2 6q27 12
SERINE/THREONINE KINASE 35; STK35 20p13 12
SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3 3p25 12
SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A 2q24 12
SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 6; SLC7A6 Chr.16 12
SPLICING FACTOR 1; SF1 11q13 12
SPLICING FACTOR, ARGININE/SERINE-RICH, 11; SFRS11 12
START DOMAIN-CONTAINING PROTEIN 13; STARD13 13q12.3 12
SUPERVILLIN; SVIL 10p11.2 12
TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN-LIKE 1; TIAL1 10q 12
TRANSPORTIN 1; TNPO1 5q13.2 12
TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A; TNRC6A 16p12 12
U22 HOST GENE 11q13 12
UBIQUITIN-SPECIFIC PROTEASE 32; USP32 17q22 12
V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 1; ETS1 11q23.3 12
V-MYC AVIAN MYELOCYTOMATOSIS VIRAL-RELATED ONCOGENE, NEUROBLASTOMA-DERIVED; MYCN 2p24.1 12
ZINC FINGER, AN1-TYPE, DOMAIN-CONTAINING PROTEIN 3; ZFAND3 6pter-p22.3 12
ABHYDROLASE DOMAIN-CONTAINING 2; ABHD2 15q26.1 11
ACTIVIN A RECEPTOR, TYPE I; ACVR1 2q23-q24 11
ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1 8q13 11
ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; ASB1 2q37 11
APOPTOSIS-ASSOCIATED TYROSINE KINASE; AATK 17q25.3 11
ARGININOSUCCINATE SYNTHETASE 1; ASS1 ARGININOSUCCINATE SYNTHETASE PSEUDOGENES, INCLUDED 9q34.1 11
ARIADNE, DROSOPHILA, HOMOLOG OF, 1; ARIH1 15q24 11
ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE; ARNTL 11p15 11
ATPase, CLASS I, TYPE 8A, MEMBER 2; ATP8A2 13q12 11
ATPase, H+ TRANSPORTING, LYSOSOMAL, 16-KD, V0 SUBUNIT C; ATP6V0C 16p13.3 11
BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6; BIRC6 2p22-p21 11
BASSOON, MOUSE, HOMOLOG OF; BSN 3p21.31 11
CADHERIN 22; CDH22 20q13.1 11
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT; CACNA1I 22q13.1 11
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-DELTA; CAMK2D 4q26 11
CASEIN KINASE I, ALPHA-1; CSNK1A1 13q13 11
CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2; CNOT2 12q15 11
CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2; CDK5RAP2 9q33.3 11
CENTROSOMAL PROTEIN, 170-KD; CEP170 1q44 11
CHIMERIN 2; CHN2 7p15.3 11
CHROMOSOME 11 OPEN READING FRAME 9; C11ORF9 11q12-q13.1 11
CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR 9p13 11
CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 3, 77-KD; CSTF3 11
COLLAGEN, TYPE IV, ALPHA-6; COL4A6 Xq22.3 11
CONTACTIN 5; CNTN5 11q21-q22.2 11
CONTACTIN 6; CNTN6 3p26-p25 11
CTD SMALL PHOSPHATASE-LIKE; CTDSPL 11
CXXC FINGER PROTEIN 5; CXXC5 5q31.3 11
CYTOSKELETON-ASSOCIATED PROTEIN 5; CKAP5 11p11.2 11
DEAD/H BOX 6; DDX6 11q23.3 11
DOT1-LIKE; DOT1L 19p13.3 11
DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1; DCDC1 11p13 11
ELONGATION FACTOR, RNA POLYMERASE II, 2; ELL2 5q15 11
ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 2; EPC2 2q23.1 11
EPHRIN RECEPTOR EphA5; EPHA5 4q13 11
ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41 1p36.2-p34 11
F-BOX AND LEUCINE-RICH REPEAT PROTEIN 10; FBXL10 11
FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 4; FAT4 4q28.1 11
FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1 8p11.2-p11.1 11
FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2 10q26 11
GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3 15q11.2-q12 11
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A 9q31.1 11
GLYCOGEN PHOSPHORYLASE, BRAIN TYPE; PYGB 20p11.2-p11.1 11
HEMICENTIN; HMCN1 1q24-q25 11
IKAROS FAMILY ZINC FINGER 4; IKZF4 12q13 11
INTEGRATOR COMPLEX SUBUNIT 3; INTS3 11
IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 2; IQSEC2 11
ISOLEUCYL-tRNA SYNTHETASE 2; IARS2 1q41 11
KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 2; KHDRBS2 11
KIAA1109 GENE; KIAA1109 4q27 11
KIAA1598 GENE; KIAA1598 11
KINASE SUPPRESSOR OF RAS 2; KSR2 12q24.2 11
LIM HOMEOBOX GENE 9; LHX9 1q31-q32 11
MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2; MARK2 11q12-q13 11
METASTASIS SUPPRESSOR 1; MTSS1 8q24.1 11
MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4; MAP2K4 17p11.2 11
MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT; MYH1 17p13.1 11
N-ETHYLMALEIMIDE-SENSITIVE FACTOR; NSF 17q21-q22 11
NEUROPEPTIDE S RECEPTOR 1; NPSR1 7p15-p14 11
NEUROPLASTIN; NPTN 15q22 11
NEVER IN MITOSIS GENE A-RELATED KINASE 6; NEK6 9q33.3-q34.11 11
NUCLEAR MITOTIC APPARATUS PROTEIN 1; NUMA1 NUMA1/RARA FUSION GENE, INCLUDED 11q13 11
PARKIN COREGULATED GENE; PACRG 6q25-q27 11
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA 22q12-q13.1 11
PHOSPHATASE AND TENSIN HOMOLOG; PTEN 10q23.31 11
PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, BETA; PIK3C2B 1q32 11
PHOSPHODIESTERASE 10A; PDE10A 11
PHOSPHOLIPASE C-LIKE 1; PLCL1 2q33 11
PLACENTA-SPECIFIC GENE 1; PLAC1 Xq26 11
POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2; KCNN2 5q21.2-q22.1 11
POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 5; KCNQ5 6q14 11
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1; KCNAB1 3q26.1 11
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 5; KCNH5 Chr.14 11
POTASSIUM CHANNEL-INTERACTING PROTEIN 4 4p15.3 11
PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12B; PPP1R12B 1q32.1 11
PROTEIN PHOSPHATASE 1-LIKE; PPM1L 3q26.1 11
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, SIGMA; PTPRS 19p13.3 11
PROTOCADHERIN 11, X-LINKED; PCDH11X Xq21.3 11
PROTOCADHERIN 17; PCDH17 13q21.1 11
RAS-ASSOCIATED PROTEIN RAB2; RAB2 8q12.1 11
RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1; RREB1 6p25 11
S-PHASE CYCLIN A-ASSOCIATED PROTEIN IN THE ENDOPLASMIC RETICULUM; SCAPER 15q24 11
SAL-LIKE 3; SALL3 18q23 11
SEMAPHORIN 3F; SEMA3F 3p21.3 11
SET-BINDING FACTOR 2; SBF2 11p15 11
SH2B ADAPTOR PROTEIN 3; SH2B3 12q24 11
SLINGSHOT, DROSOPHILA, HOMOLOG OF, 2 Chr.17 11
SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A 2q24 11
SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8 20q13.13 11
SPONDIN 1; SPON1 Chr.11 11
STERILE ALPHA MOTIF DOMAIN-CONTAINING 4A; SAMD4A 14q22.2 11
SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2; SMARCA2 9p24-p23 11
SYNAPSIN II; SYN2 3p25 11
T-BOX 15; TBX15 1p13 11
THIAMINE PYROPHOSPHOKINASE; TPK1 7q34 11
THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 7A; THSD7A 7p21.3 11
TRANSCRIPTION FACTOR AP2-DELTA; TFAP2D 6p21.1-p12.1 11
TRANSDUCIN-LIKE ENHANCER OF SPLIT 3; TLE3 15q22 11
TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III; TGFBR3 1p33-p32 11
TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2; TMEFF2 2q32-q33 11
TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 5; TTLL5 14q24.3 11
TUBULIN, BETA; TUBB 6p21.3 11
UBIQUITIN-PROTEIN LIGASE E3A; UBE3A 15q11-q13 11
UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON Y CHROMOSOME; UTY Yq11 11
UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14; GALNT14 2p23.2 11
V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG; MAF 16q22-q23 11
V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG 1, LUNG CARCINOMA-DERIVED; MYCL1 1p34.3 11
VISININ-LIKE 1; VSNL1 2p 11
WD REPEAT-CONTAINING PROTEIN 10; WDR10 3q21 11
X INACTIVATION-SPECIFIC TRANSCRIPT; XIST X INACTIVATION CENTER, INCLUDED; XIC, INCLUDED Xq13.2 11
ACTIVATING TRANSCRIPTION FACTOR 2; ATF2 2q32 10
ADAPTOR-RELATED PROTEIN COMPLEX 2, BETA-1 SUBUNIT; AP2B1 17q11.2-q12 10
ADENYLATE CYCLASE 6; ADCY6 12q12-q13 10
ANDROGEN-INDUCED PROSTATE PROLIFERATIVE SHUTOFF-ASSOCIATED PROTEIN 13q12.3 10
ASPARTYL-tRNA SYNTHETASE; DARS 10
ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE; ATP1A3 19q12-q13.2 10
AUTOPHAGY 7, S. CEREVISIAE, HOMOLOG OF; ATG7 10
BCL2-ASSOCIATED TRANSCRIPTION FACTOR 1; BCLAF1 6q22-q23 10
BRF1, S. CEREVISIAE, HOMOLOG OF; BRF1 14q 10
CADHERIN 2; CDH2 18q11.2 10
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, N TYPE, ALPHA-1B SUBUNIT; CACNA1B 9q34 10
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A 19p13 10
CALDESMON 1; CALD1 7q33 10
CARBOXYPEPTIDASE A6; CPA6 10
CCCTC-BINDING FACTOR; CTCF 16q22.1 10
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2; CHD2 15q26 10
CHROMODOMAIN PROTEIN ON Y CHROMOSOME-LIKE; CDYL 6p25.1 10
CLATHRIN, HEAVY POLYPEPTIDE; CLTC 17q23 10
COLLAGEN, TYPE I, ALPHA-1; COL1A1 17q21.31-q22 10
CUB AND SUSHI MULTIPLE DOMAINS 2; CSMD2 1p35.3 10
DCN1 DOMAIN-CONTAINING PROTEIN 4; DCUN1D4 4q12 10
DEAD/H BOX 17; DDX17 22q13.1 10
DEDICATOR OF CYTOKINESIS 10; DOCK10 2q36.2 10
DELETED IN BLADDER CANCER 1; DBC1 9q32-q33 10
DELETED IN ESOPHAGEAL CANCER 1; DEC1 9q32 10
DIACYLGLYCEROL KINASE, GAMMA, 90-KD; DGKG 3q27-q28 10
DISCS LARGE-ASSOCIATED PROTEIN 1; DLGAP1 10
DNA METHYLTRANSFERASE 3A; DNMT3A 2p23 10
DOPAMINE RECEPTOR D3; DRD3 3q13.3 10
DYNEIN, AXONEMAL, HEAVY CHAIN 11; DNAH11 7p21 10
EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2 10q26.1 10
EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2; EEF1B2 2q33-q34 10
EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 1; EIF4A1 17p13 10
FERM, ARHGEF, AND PLECKSTRIN DOMAIN-CONTAINING PROTEIN 1; FARP1 10
FERRITIN HEAVY CHAIN 1; FTH1 11q12-q13 10
FIBROBLAST GROWTH FACTOR 13; FGF13 Xq26.3 10
FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3; FLRT3 20p11 10
FMS-RELATED TYROSINE KINASE 1; FLT1 13q12 10
FRIZZLED, DROSOPHILA, HOMOLOG OF, 1; FZD1 7q21 10
G PROTEIN-COUPLED RECEPTOR 126; GPR126 6q24.1 10
GLYCINE RECEPTOR, ALPHA-2 SUBUNIT; GLRA2 Xp22.1-p21.2 10
GREMLIN 2 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM2 1q43 10
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2; GNAI2 3p21 10
H19 GENE; H19 11p15.5 10
HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3A1; HS3ST3A1 17p12-p11.2 10
HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 2A; HISPPD2A 15q15.3 10
HISTONE 1, H1D; HIST1H1D 6p21.3 10
IKAROS FAMILY ZINC FINGER 1; IKZF1 7p12 10
ISLET CELL AUTOANTIGEN 1; ICA1 7p22 10
KARYOPHERIN ALPHA-3; KPNA3 13q14.3 10
KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 1; KREMEN1 22q12.1 10
LAMININ, GAMMA-1; LAMC1 1q31 10
LIM DOMAIN KINASE 2; LIMK2 10
LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4 11p12-p11.2 10
LYSOSOMAL TRAFFICKING REGULATOR; LYST 1q42.1-q42.2 10
MITOCHONDRIAL RIBOSOMAL PROTEIN S25; MRPS25 3p25 10
MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 6; MLLT6 17q21 10
MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 11; MEGF11 15q22.31 10
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA 2; MLL2 12q12-q14 10
MYOSIN IE; MYO1E 15q21-q22 10
MYOSIN IXA; MYO9A 15q22-q23 10
MYOSIN VIIA- AND RAB-INTERACTING PROTEIN; MYRIP 3p21.33-p21.32 10
MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA; MYH6 14q12 10
OLIGOPHRENIN 1; OPHN1 Xq12 10
ONE CUT HOMEOBOX 2; ONECUT2 18q21.1-q21.2 10
ORTHOPEDIA, DROSOPHILA, HOMOLOG OF; OTP 5q13.3 10
PAIRED BASIC AMINO ACID CLEAVING ENZYME 4; PACE4 15q26 10
PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA 3q26.3 10
PHOSPHOLIPASE C, BETA-1; PLCB1 10
PHOSPHOLIPASE C, EPSILON-1; PLCE1 10q23 10
PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING 1; PID1 2q36.3 10
PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1 11q23.3 10
POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 1; KCNA1 12p13 10
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 7; KCNH7 2q24.2 10
PRICKLE-LIKE 2; PRICKLE2 10
PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5; PCSK5 9q21.3 10
PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, BETA; PRKACB 1p36.1 10
PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1A; PPM1A 10
PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 4; RIMS4 20q13.3 10
PROTOCADHERIN 11, Y-LINKED; PCDH11Y Yp11.2 10
RAB6-INTERACTING PROTEIN 2; RAB6IP2 10
RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 6; RGPD6 2q12.3-q13 10
RAS p21 PROTEIN ACTIVATOR 3 13q34 10
RAS-ASSOCIATED PROTEIN RAB7; RAB7 3q21 10
REGULATOR OF G PROTEIN SIGNALING 6; RGS6 14q24.3 10
RETINOBLASTOMA-BINDING PROTEIN 6; RBBP6 16p12-p11.2 10
RETINOIC ACID RECEPTOR, GAMMA; RARG 12q13 10
REV3, S. CEREVISIAE, HOMOLOG OF; REV3L 6q21 10
RHABDOID TUMOR DELETION REGION GENE 1; RTDR1 22q11.2 10
RIBONUCLEASE III, NUCLEAR; RNASEN 5p14-p13 10
RIBOSOMAL PROTEIN L21; RPL21 13q 10
RIC8, C. ELEGANS, HOMOLOG OF, B 10
SHROOM FAMILY MEMBER 4; SHROOM4 Xp11.2 10
SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 1; SCUBE1 22q13 10
SLIT, DROSOPHILA, HOMOLOG OF, 1; SLIT1 10
SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 1; SLC12A1 15q15-q21.1 10
SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12; SLC25A12 2q24 10
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, TAURINE), MEMBER 6; SLC6A6 3p25-q24 10
SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 1; SLC7A1 13q12.3 10
SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 2; SMOC2 6q72 10
SUPPRESSOR OF FUSED, DROSOPHILA, HOMOLOG OF; SUFU 10q24-q25 10
SUPPRESSOR OF TUMORIGENICITY 5; ST5 11p15 10
T-CELL TRANSCRIPTION FACTOR EB; TFEB 6p21 10
TAF4B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 105-KD; TAF4B 18q11.2 10
TETRATRICOPEPTIDE REPEAT, ANKYRIN REPEAT, AND COILED-COIL-CONTAINING PROTEIN 1; TANC1 10
TIGHT JUNCTION PROTEIN 1; TJP1 15q13 10
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5; TRPC5 Xq23 10
TRANSMEMBRANE PROTEIN 49; TMEM49 17q23.1 10
TUBULIN POLYMERIZATION-PROMOTING PROTEIN; TPPP 5p15.3 10
UBIQUITIN-SPECIFIC PROTEASE 22; USP22 17p11.2 10
UBIQUITIN-SPECIFIC PROTEASE 2; USP2 10
UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 13; GALNT13 2q24.1 10
UDP-N-ACETYLGLUCOSAMINE:ALPHA-1,3-D-MANNOSIDE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE IV 12q21 10
VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF 6p12 10
VAV3 ONCOGENE; VAV3 10
VENTROPTIN Xq22.1-q23 10
ZINC FINGER E BOX-BINDING HOMEOBOX 1; ZEB1 10p11.2 10
ZINC FINGER PROTEIN 148; ZNF148 3q21 10
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 10; ADAMTS10 19p13.3-p13.2 9
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 17; ADAMTS17 9
ACONITASE, MITOCHONDRIAL; ACO2 22q11.21-q13.31 9
ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM 3q13.1-q13.2 9
ACTIVATING TRANSCRIPTION FACTOR 7; ATF7 Chr.12 9
ADAMTS-LIKE PROTEIN 3; ADAMTSL3 15q25.2 9
ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-2 SUBUNIT; AP3B2 15q 9
ADENYLATE CYCLASE 1; ADCY1 7p13-p12 9
ADENYLATE CYCLASE 8; ADCY8 8q24.2 9
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1; APBA1 9q13 9
AMYLOID BETA A4 PRECURSOR PROTEIN; APP 21q21 9
ANKYRIN 1; ANK1 8p11.2 9
ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1A; ANKS1A 6p21.3 9
ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR 2; ARNT2 15q24 9
ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 5; ABCC5 3q27 9
ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1; ABCG1 21q22.3 9
ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2 12q23-q24.1 9
AUTOPHAGY 16-LIKE 1; ATG16L1 2q37.1 9
BROMODOMAIN AND PHD FINGER-CONTAINING PROTEIN; BRPF1 3p26-p25 9
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1; CACNA2D1 7q21-q22 9
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; CACNB1 17q21-q22 9
CARBAMOYL PHOSPHATE SYNTHETASE I; CPS1 VENOOCCLUSIVE DISEASE AFTER BONE MARROW TRANSPLANTATION, SUSCEPTIBILITY TO, INCLUDED 2q35 9
CARBOHYDRATE SULFOTRANSFERASE 9; CHST9 9
CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 2; ACCN2 12q12 9
CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6; CNOT6 5q35.3 9
CELL ADHESION MOLECULE-RELATED/DOWNREGULATED BY ONCOGENES; CDON 9
CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6; CPSF6 Chr.12 9
COFACTOR REQUIRED FOR SP1 TRANSCRIPTIONAL ACTIVATION, SUBUNIT 7; CRSP7 19p13.11 9
COLD-INDUCIBLE RNA-BINDING PROTEIN; CIRBP 19p13.3 9
COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1 9q32 9
COP9, SUBUNIT 2; COPS2 15q21.2 9
CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2, TRANSLOCATED TO, 2; CBFA2T2 20q11.2 9
CULLIN 2; CUL2 10p11.2-p11.1 9
CYTOCHROME P450, SUBFAMILY XXVIB, POLYPEPTIDE 1; CYP26B1 9
DEAD/H BOX 15; DDX15 4p15.3 9
DEAD/H BOX 3, Y-LINKED; DDX3Y Yq11 9
DEDICATOR OF CYTOKINESIS 3; DOCK3 3p14 9
DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 5; DNAJB5 9
DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 1; DNAJC1 9
DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2; DYRK2 12q14 9
DYNEIN, AXONEMAL, HEAVY CHAIN 8; DNAH8 6p21 9
DYSTROBREVIN, BETA; DTNB 2p23-p22 9
E1A-BINDING PROTEIN, 300-KD; EP300 22q13 9
EGF-LIKE REPEATS- AND DISCOIDIN I-LIKE DOMAINS-CONTAINING PROTEIN 3; EDIL3 9
ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE; ETFA 15q23-q25 9
ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1 2p21-p16 9
EPHRIN RECEPTOR EphB3; EPHB3 3q21-qter 9
ESTROGEN-RELATED RECEPTOR, BETA; ESRRB 14q24.3 9
EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 1; EIF2C1 1p35-p34 9
EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 3; EIF4G3 9
EUKARYOTIC TRANSLATION INITIATION FACTOR 5; EIF5 9
EWING SARCOMA BREAKPOINT REGION 1; EWSR1 22q12 9
EXORIBONUCLEASE 2; XRN2 DHM1-LIKE PROTEIN 20p11.2-p11.1 9
F-BOX ONLY PROTEIN 11; FBXO11 2p21 9
FOUR-AND-A-HALF LIM DOMAINS 3; FHL3 1p34 9
FRAGILE X MENTAL RETARDATION, AUTOSOMAL HOMOLOG 1; FXR1 3q28 9
G PROTEIN-COUPLED RECEPTOR 98; GPR98 5q14 9
GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3 15q11.2-q12 9
GLUTAMATE RECEPTOR, METABOTROPIC, 4; GRM4 6p21.3 9
GLYCOGEN BRANCHING ENZYME; GBE1 3p12 9
GLYCOGEN STORAGE DISEASE VI 14q21-q22 9
GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2-LIKE 1; GNB2L1 9
HELICASE WITH ZINC FINGER DOMAIN; HELZ Chr.17 9
HEPATITIS B VIRUS X-ASSOCIATED PROTEIN; HBXAP 11q13 9
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HNRNPH1 5q35.3 9
HUNTINGTIN-INTERACTING PROTEIN 1; HIP1 HIP1/PDGFRB FUSION GENE, INCLUDED 7q11.23 9
HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1 9
IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4D; IGSF4D 3p12 9
IMMUNOGLOBULIN: HEAVY EPSILON CHAIN; IGHE 14q32.33 9
INSULIN-LIKE GROWTH FACTOR I; IGF1 12q22-q24.1 9
JUNCTOPHILIN 1; JPH1 8q21 9
La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 1; LARP1 5q33.2 9
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D; LRRC8D 1p22.2 9
LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 1; LRIG1 3p14 9
LIPIN 2; LPIN2 18p 9
LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1 4q23-q25 9
MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF 22q11.2 9
MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 1; MDGA1 6p21 9
MATRIN 3; MATR3 5q31.2 9
MEGAKARYOBLASTIC LEUKEMIA 1 GENE; MKL1 22q13 9
METHYL-CpG-BINDING DOMAIN PROTEIN 5; MBD5 2q23.1 9
MICROTUBULE-ASSOCIATED PROTEIN 2; MAP2 2q34-q35 9
MITOGEN-ACTIVATED KINASE KINASE KINASE 3; MAP3K3 9
MOESIN; MSN Xq11.2-q12 9
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 7; SMAD7 18q21.1 9
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 4; MLLT4 6q27 9
MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC; MYH3 17p13.1 9
MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9 22q11.2 9
MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS 6q22.2 9
NADPH OXIDASE 3; NOX3 6q25.1 9
NCK-ASSOCIATED PROTEIN 1; NCKAP1 2q32.1-q32.2 9
NITRIC OXIDE SYNTHASE 1 (NEURONAL) ADAPTOR PROTEIN; NOS1AP 1q23.3 9
NUCLEAR RECEPTOR COREPRESSOR 1; NCOR1 9
OXYSTEROL-BINDING PROTEIN 2; OSBP2 22q12 9
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, BETA; PPARGC1B 5q33 9
PHD FINGER PROTEIN 15; PHF15 9
PHOSPHATE-REGULATING ENDOPEPTIDASE HOMOLOG, X-LINKED; PHEX Xp22.2-p22.1 9
PHOSPHATIDIC ACID PHOSPHATASE TYPE 2B; PPAP2B 9
PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PITPN 17p13.3 9
PHOSPHODIESTERASE 4D-INTERACTING PROTEIN; PDE4DIP 9
PHOSPHOGLUCOMUTASE 5; PGM5 9p12-q12 9
PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 7; PLEKHA7 11p15.1 9
PLECTIN 1; PLEC1 8q24 9
PLEXIN C1; PLXNC1 Chr.12 9
POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 1; KCND1 9
POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 2; POU2F2 19q13.2 9
POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 1; POU3F1 1p34.1 9
PRICKLE-LIKE 1; PRICKLE1 12q12 9
PRION PROTEIN; PRNP 20pter-p12 9
PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2 20p11.2 9
PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), EPSILON; PPP2R5E 14q23.1 9
PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), GAMMA; PPP2R5C 3p21 9
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-2; PPFIA2 9
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O; PTPRO 12p13-p12 9
PUMILIO, DROSOPHILA, HOMOLOG OF, 2; PUM2 2p22-p21 9
RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT; RABGGTB 1p31 9
RAB GTPase-ACTIVATING PROTEIN 1-LIKE; RABGAP1L 9
RAN-BINDING PROTEIN 2; RANBP2 2q11-q13 9
RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 5; RGPD5 2q12.3-q13 9
RAP1, GTPase-ACTIVATING PROTEIN 1; RAP1GA1 1p36.1-p35 9
RAS-ASSOCIATED PROTEIN RAB3C; RAB3C 5q13 9
RAS-ASSOCIATED PROTEIN RAB5C; RAB5C 17q21.2 9
RESTIN; RSN 12q24.31-q24.33 9
RETICULON 1; RTN1 14q21-q22 9
RETINOIC ACID-INDUCED 2; RAI2 Xp22 9
RETINOID X RECEPTOR, ALPHA; RXRA 9q34.3 9
RGM DOMAIN FAMILY, MEMBER A; RGMA 15q26.1 9
RIBOSOMAL PROTEIN L10; RPL10 Xq28 9
RIBOSOMAL PROTEIN L30; RPL30 Chr.8 9
RIBOSOMAL PROTEIN S27a; RPS27A 9
RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING 1; RC3H1 1q25.1 9
RING1- AND YY1-BINDING PROTEIN; RYBP 3p13 9
RNA GUANYLYLTRANSFERASE AND 5-PRIME-PHOSPHATASE; RNGTT 6q16 9
S-ADENOSYLHOMOCYSTEINE HYDROLASE-LIKE 1; AHCYL1 9
SAL-LIKE 1; SALL1 16q12.1 9
SEC14-LIKE 2; SEC14L2 22q12.1-qter 9
SEC24-RELATED GENE FAMILY, MEMBER C; SEC24C 9
SEMAPHORIN 6D; SEMA6D 9
SEPTIN 3; SEPT3 22q13.2 9
SEPTIN 7; SEPT7 7p14 9
SEPTIN 9; SEPT9 17q25 9
SERINE/ARGININE REPETITIVE MATRIX PROTEIN 1; SRRM1 1p36.11 9
SIDEKICK, DROSOPHILA, HOMOLOG OF, 2; SDK2 9
SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2 1q32.1 9
SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 1; SMURF1 7q21.1-q31.1 9
SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 2; SMURF2 9
SNF2-RELATED CBP ACTIVATOR PROTEIN 9
SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A 17q23.1-q25.3 9
SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2 20p13-p12 9
SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK 5q31 9
SPLICING FACTOR, ARGININE/SERINE-RICH, 1; SFRS1 17q21.3-q22 9
SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1; SPRED1 15q13.2 9
SRY-BOX 4; SOX4 6p22.3 9
STANNIOCALCIN 1; STC1 8p21-p11.2 9
SUCCINATE-CoA LIGASE, GDP-FORMING, BETA SUBUNIT; SUCLG2 9
SUPPRESSOR OF TY 6, S. CEREVISIAE, HOMOLOG OF; SUPT6H 17q11.2 9
SYNTAXIN 18; STX18 9
TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 140-KD; TAF3 10p15.1 9
THREONINE ASPARTASE 1; TASP1 20p12.1 9
THROMBOXANE A SYNTHASE 1; TBXAS1 7q34 9
THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 1; THRAP1 Chr.17 9
THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 2; THRAP2 12q24 9
TRANSCRIPTION FACTOR 7-LIKE 1; TCF7L1 9
TRANSCRIPTION FACTOR Sp3; SP3 SP3/EWS FUSION GENE, INCLUDED 2q31 9
TRANSDUCER OF ERBB2, 2; TOB2 22q13.1-q13.31 9
TRANSFORMING GROWTH FACTOR, BETA-2; TGFB2 1q41 9
TRIPARTITE MOTIF-CONTAINING PROTEIN 9; TRIM9 14q21-q24 9
TSC22 DOMAIN FAMILY, MEMBER 3; TSC22D3 Xq22.2 9
TSR1, 20S rRNA ACCUMULATION, S. CEREVISIAE, HOMOLOG OF; TSR1 9
TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, GAMMA ISOFORM; YWHAG 7q11.23 9
UBIQUITIN C; UBC 12q24.3 9
UBIQUITIN PROTEIN LIGASE NEDD4-LIKE; NEDD4L 18q21 9
UBIQUITIN-CONJUGATING ENZYME E2E 2; UBE2E2 3p24.2 9
UBIQUITIN-SPECIFIC PROTEASE 7; USP7 16p13.3 9
UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE-LIKE; B3GALTL 13q12.3 9
UNC5, C. ELEGANS, HOMOLOG OF, B; UNC5B 10q21-q22 9
URONYL 2-SULFOTRANSFERASE; UST 6q25.1 9
UTROPHIN; UTRN 6q24 9
V-SKI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; SKI 1p36.3 9
VASCULAR ENDOTHELIAL ZINC FINGER 1; VEZF1 17q22 9
ZINC FINGER AND HOMEODOMAIN PROTEIN 2; ZHX2 9
ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11; ZMYND11 9
ZINC FINGER PROTEIN 207; ZNF207 6p21.3 9
ZINC FINGER PROTEIN 265; ZNF265 1p22.1-p21.3 9
ZINC FINGER PROTEIN, MULTITYPE 1; ZFPM1 16q24.3 9
ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 40; ZBTB40 1p36 9
ZINC FINGER- AND RAN-BINDING DOMAIN-CONTAINING PROTEIN 1; ZRANB1 10q26.13 9
5-@HYDROXYTRYPTAMINE RECEPTOR 3B; HTR3B 11q23.1 8
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3; ADAMTS3 4q21 8
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9 3p14.3-p14.2 8
ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1 9q34.1 8
ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE 22q12.3-q13.1 8
ACTININ, ALPHA-4; ACTN4 19q13 8
ACTIVATING TRANSCRIPTION FACTOR 6; ATF6 1q22-q23 8
ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT; AP3D1 8
ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARFGEF2 20q13.13 8
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2 15q 8
ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, BETA SUBUNIT; ATP5B 12p13-qter 8
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 12; ABCA12 2q34 8
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2 9q34 8
ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 4; ABCC4 13q32 8
ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2 3p26-p25 8
ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 1; ATP6V0D1 16q22 8
BCL2-MODIFYING FACTOR; BMF 15q14 8
BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1; BACE1 11q23.3 8
BONE MORPHOGENETIC PROTEIN-BINDING ENDOTHELIAL CELL PRECURSOR-DERIVED REGULATOR 8
BR SERINE/THREONINE KINASE 2; BRSK2 8
BREAST CANCER-OVEREXPRESSED GENE 1 8
BROMODOMAIN-CONTAINING PROTEIN 2; BRD2 6p21.3 8
BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1; BBOX1 Chr.11 8
C-TERMINAL-BINDING PROTEIN 2; CTBP2 10q26.13 8
CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 1; CELSR1 22q13.3 8
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT; CACNG3 16p13.1-p12 8
CALMODULIN 1; CALM1 14q24-q31 8
CAPICUA, DROSOPHILA, HOMOLOG OF; CIC 19q13.2 8
CATENIN, BETA-1; CTNNB1 3p22-p21.3 8
CELL ADHESION MOLECULE, NEURAL, 2; NCAM2 21q21 8
CERAMIDE KINASE-LIKE; CERKL 2q31.2-q32.3 8
CHOLINE TRANSPORTER-LIKE PROTEIN 1 9q31.2 8
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1; CHD1 5q15-q21 8
CLIP-ASSOCIATED PROTEIN 2 3p22.3 8
COFACTOR REQUIRED FOR SP1 TRANSCRIPTIONAL ACTIVATION, SUBUNIT 2; CRSP2 Xp11.4-p11.2 8
COLLAGEN, TYPE IV, ALPHA-1; COL4A1 13q34 8
COLLAGEN, TYPE V, ALPHA-1; COL5A1 9q34.2-q34.3 8
COLLAGEN, TYPE VIII, ALPHA-1; COL8A1 3q12-q13.1 8
COLLAGEN, TYPE XI, ALPHA-1; COL11A1 1p21 8
CONNECTIVE TISSUE GROWTH FACTOR; CTGF 6q23.1 8
CONNECTOR ENHANCER OF KSR 2; CNKSR2 Xp22.12 8
CONTACTIN 1; CNTN1 12q11-q12 8
CORDON-BLEU, MOUSE, HOMOLOG OF; COBL 8
CORONIN 2B; CORO2B 15q23 8
CREB-BINDING PROTEIN; CREBBP 16p13.3 8
CULLIN 5; CUL5 11q22-q23 8
CYCLIN D2; CCND2 12p13 8
CYCLIN-DEPENDENT KINASE 6; CDK6 7q21-q22 8
DIGEORGE SYNDROME CRITICAL REGION GENE 8; DGCR8 22q11.2 8
DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, C; DIP2C 10p15.3 8
DISCS LARGE, DROSOPHILA, HOMOLOG OF, 4; DLG4 17p13.1 8
DUAL-SPECIFICITY PHOSPHATASE 6; DUSP6 12q22-q23 8
ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1 14q32 8
ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENTPD1 10q24 8
EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7 8
EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1; EEF1A1 6q14 8
EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 2; EIF2C2 8q24 8
EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 4; EIF2C4 1p35-p34 8
EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT C; EIF3C 16p11.2 8
EXOSTOSIN-LIKE 3; EXTL3 8p21 8
F-BOX ONLY PROTEIN 33; FBXO33 14q13.3 8
FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER C; FAM53C 8
FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER A; FAM84A 8
FMR1 GENE; FMR1 Xq27.3 8
FRIZZLED, DROSOPHILA, HOMOLOG OF, 2; FZD2 17q21.1 8
FRIZZLED, DROSOPHILA, HOMOLOG OF, 8; FZD8 10p11.2 8
GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1; GABRB1 4p13-p12 8
GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2; GABRB2 5q34-q35 8
GATA-BINDING PROTEIN 3; GATA3 10p15 8
GLUCOCORTICOID RECEPTOR DNA-BINDING FACTOR 1; GRLF1 19q13.2-q13.4 8
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1 9q34.3 8
GLUTAMATE RECEPTOR, METABOTROPIC, 5; GRM5 8
GLUTAMINASE, PHOSPHATE-ACTIVATED; GLS 2q32-q34 8
GLYCINE RECEPTOR, ALPHA-1 SUBUNIT; GLRA1 5q32 8
GLYCOGEN PHOSPHORYLASE, MUSCLE; PYGM 11q13 8
GLYCOPROTEIN M6A; GPM6A 4q34 8
GNAS COMPLEX LOCUS; GNAS 20q13.2 8
GRB10-INTERACTING GYF PROTEIN 2; GIGYF2 2q37.1 8
GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1 4q13.1 8
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE; GNAZ 22q11.2 8
HEAT-SHOCK 70-KD PROTEIN 1B; HSPA1B 6p21.3 8
HEAT-SHOCK 70-KD PROTEIN 5; HSPA5 9q34 8
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; HNRNPR 1p36.11 8
HISTONE 1, H1E; HIST1H1E 6p21.3 8
HISTONE 1, H2BA; HIST1H2BA 6p22.2 8
HISTONE 1, H3H; HIST1H3H 6p22-p21.3 8
HISTONE 1, H4J; HIST1H4J 6p22-p21.3 8
HISTONE ACETYLTRANSFERASE MYST3; MYST3 8p11 8
HLA-B-ASSOCIATED TRANSCRIPT 2; BAT2 6p21.3 8
HOMEODOMAIN-INTERACTING PROTEIN KINASE 1; HIPK1 8
HUNTINGTIN-INTERACTING PROTEIN 2; HIP2 4p14 8
HUNTINGTIN; HTT 4p16.3 8
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A 14q21-q24 8
INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; IMMP1L 11p13 8
INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 2; ITPR2 12p11 8
INSULIN RECEPTOR SUBSTRATE 1; IRS1 CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO, INCLUDED 2q36 8
INSULIN-DEGRADING ENZYME; IDE 10q23-q25 8
INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1; IGF2BP1 17q21.3 8
INTERFERON INDUCED WITH HELICASE C DOMAIN PROTEIN 1; IFIH1 2q24 8
INTERSECTIN 2; ITSN2 2p25 8
JAGGED 1; JAG1 20p12 8
KATANIN, p80 SUBUNIT, B1; KATNB1 8
KCNQ1-OVERLAPPING TRANSCRIPT 1; KCNQ1OT1 11p15.5 8
KIAA1199 15q24 8
KINESIN FAMILY MEMBER 21B; KIF21B 1q31-q32 8
LAMININ, ALPHA-2; LAMA2 6q22-q23 8
LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5 12q15-q23 8
LHFP-LIKE PROTEIN 2; LHFPL2 5q14.1 8
LHFP-LIKE PROTEIN 3; LHFPL3 7q22.1 8
LIM DOMAIN ONLY 2; LMO2 11p13 8
LIM DOMAIN-CONTAINING PROTEIN 1; LIMD1 3p21.3 8
LIM HOMEOBOX GENE 2; LHX2 9q33-q34.1 8
LIMB REGION 1, MOUSE, HOMOLOG OF; LMBR1 7q36 8
LIN7, C. ELEGANS, HOMOLOG OF, A; LIN7A 8
LUNATIC FRINGE; LFNG 7p22 8
MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE D; MEF2D 1q12-q23 8
MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 1; MAN1A1 6q22 8
MASTERMIND-LIKE 2; MAML2 11q21 8
MCF2-LIKE PROTEIN; MCF2L 8
METHIONINE ADENOSYLTRANSFERASE II, ALPHA; MAT2A 2p11.2 8
METHYL-CpG-BINDING DOMAIN PROTEIN 3; MBD3 19p13.3 8
METHYL-CpG-BINDING PROTEIN 2; MECP2 Xq28 8
MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1 1p32-p31 8
MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2; MICAL2 11p15.3 8
MITOGEN-ACTIVATED PROTEIN KINASE 10; MAPK10 4q21.3 8
MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6; MAP2K6 1p36.11 8
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 6; SMAD6 15q21-q22 8
MUSKELIN 1; MKLN1 7q32 8
N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA 19q13.3 8
Na+/K+ TRANSPORTING ATPase-INTERACTING 3; NKAIN3 8q12.13 8
NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 1; NKD1 8
NEL-LIKE 1; NELL1 11p15.2-p15.1 8
NEL-LIKE 2; NELL2 12q13.11-q13.12 8
NEURONAL CELL ADHESION MOLECULE; NRCAM 7q31.1-q31.2 8
NIK-RELATED KINASE; NRK Xq22.3 8
NITRIC OXIDE SYNTHASE 1; NOS1 NITRIC OXIDE SYNTHASE, NEURONAL, INCLUDED 12q24.2-q24.31 8
NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3 19p13.2-p13.1 8
NUCLEOLAR PROTEIN 4; NOL4 8
OXIDATION RESISTANCE 1; OXR1 8q23 8
PALLADIN, MOUSE, HOMOLOG OF; PALLD 4q32.3 8
PANTOTHENATE KINASE 3 5q35 8
PARVIN, ALPHA; PARVA 8
PAXILLIN; PXN 12q24 8
PCF11, YEAST, HOMOLOG OF 8
PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L 3q26.2-q27 8
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD 6p21.2-p21.1 8
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG PPARG1, INCLUDED 3p25 8
PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC, 1; PITPNC1 8
PHOSPHODIESTERASE 3A, cGMP-INHIBITED; PDE3A 8
PHOSPHORYLASE KINASE, BETA SUBUNIT; PHKB 16q12-q13 8
PICCOLO, MOUSE, HOMOLOG OF; PCLO 7q11.23-q21.1 8
PLEXIN A1; PLXNA1 3q21-qter 8
POLY(rC)-BINDING PROTEIN 3; PCBP3 21q22.3 8
POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1; PABPC1 8q22 8
POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 4; PABPC4 1p36-p32 8
POLYHOMEOTIC-LIKE 2; PHC2 8
POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2 1p21 8
POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 3; KCNN3 1q21.3 8
POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10 1q23.2 8
POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1 9q34.3 8
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 6; KCNH6 8
POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3; POU2F3 11q23.3 8
PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2; PDSS2 6q21 8
PROSTATE CANCER ANTIGEN 3; PCA3 9q21-q22 8
PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 2; SRPK2 8
PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9A; PPP1R9A 7q21.3 8
PROTOCADHERIN 10; PCDH10 4q28.3 8
PROTOCADHERIN 15; PCDH15 10q21-q22 8
R-SPONDIN FAMILY, MEMBER 2; RSPO2 8
RABPHILIN 3A; RPH3A 12q24.1 8
RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 2; REPS2 Chr.X 8
RAS p21 PROTEIN ACTIVATOR 1; RASA1 5q13.3 8
RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; RASGRF1 8
RAS SUPPRESSOR PROTEIN 1; RSU1 10p13 8
RAS-ASSOCIATED PROTEIN RAB6A; RAB6A 2q14-q21 8
REGULATOR OF NONSENSE TRANSCRIPTS 1; RENT1 19p13.2-p13.11 8
REST COREPRESSOR; RCOR Chr.14 8
RETINOIC ACID-INDUCED GENE 1; RAI1 17p11.2 8
RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17 16p12.2 8
RIBOSOMAL PROTEIN L12; RPL12 9q33.3 8
RIBOSOMAL PROTEIN S12; RPS12 6q 8
RIBOSOMAL PROTEIN S3; RPS3 11q13.3-q13.5 8
RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 1; RPS6KB1 8
RNA TERMINAL PHOSPHATE CYCLASE-LIKE 1; RCL1 8
S-ADENOSYLMETHIONINE DECARBOXYLASE; AMD1 6q21-q22 8
SEPTIN 11; SEPT11 4q21.1 8
SERINE/THREONINE PROTEIN KINASE 33; STK33 11p15.3 8
SERUM RESPONSE FACTOR; SRF 8
SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1 11p15.3 8
SHB ADAPTOR PROTEIN; SHB 9p12-p11 8
SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 1; SIM1 6q16.3-q21 8
SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A 3p21 8
SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5 20q12-q13.1 8
SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2; SLC16A2 Xq13.2 8
SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3 8
SOLUTE CARRIER FAMILY 9, MEMBER 6; SLC9A6 Xq26.3 8
SOLUTE CARRIER FAMILY 9, MEMBER 7; SLC9A7 Xp11.3 8
SON OF SEVENLESS, DROSOPHILA, HOMOLOG 1; SOS1 2p22-p21 8
SORBIN AND SH3-DOMAINS CONTAINING 1; SORBS1 10q23.3-q24.1 8
SORTING NEXIN 13; SNX13 7p21.1 8
SORTING NEXIN 1; SNX1 SORTING NEXIN 1A, INCLUDED; SNX1A, INCLUDED 15q22.3 8
SORTING NEXIN 5; SNX5 20p11 8
SPECKLE-TYPE POZ PROTEIN; SPOP 8
SPINDLIN; SPIN 9q22.1-q22.3 8
STROMAL MEMBRANE-ASSOCIATED PROTEIN 1; SMAP1 8
SUPPRESSOR OF CLEAR, C. ELEGANS, HOMOLOG OF; SHOC2 10q25 8
SUPPRESSOR OF MEK1, DICTYOSTELIUM, HOMOLOG OF, 1; SMEK1 8
SUPPRESSOR OF TY 5, S. CEREVISIAE, HOMOLOG OF; SUPT5H 19q13.1-q13.2 8
SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 5; SMARCA5 4q31.1-q31.2 8
SYNAPTIC NUCLEAR ENVELOPE PROTEIN 2; SYNE2 14q23 8
SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1 6p21.3 8
SYNTAXIN-BINDING PROTEIN 6; STXBP6 8
TAR DNA-BINDING PROTEIN; TARDBP 1p36.2 8
THYROTROPH EMBRYONIC FACTOR; TEF 22q13 8
TNF RECEPTOR-ASSOCIATED FACTOR 4; TRAF4 8
TRANSCRIPTION FACTOR 7; TCF7 5q31.1 8
TRANSCRIPTION FACTOR Sp4; SP4 7p15 8
TRANSDUCER OF ERBB2, 1; TOB1 17q21 8
TRANSDUCIN-BETA-LIKE 1 RECEPTOR 1; TBL1XR1 8
TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1 9q22 8
TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1 9q13-q21 8
TRANSMEMBRANE PROTEIN 113; TMEM113 3p21.1 8
TRINUCLEOTIDE REPEAT-CONTAINING GENE 6C; TNRC6C 17q25.3 8
TRIPARTITE MOTIF-CONTAINING PROTEIN 33; TRIM33 1p13 8
TROPOMYOSIN 1; TPM1 15q22.1 8
TSC22 DOMAIN FAMILY, MEMBER 1; TSC22D1 13q14 8
UBINUCLEIN 1; UBN1 16p13.3 8
UNC13, C. ELEGANS, HOMOLOG OF, A; UNC13A 19q13.3 8
WOLF-HIRSCHHORN SYNDROME CANDIDATE 1; WHSC1 4p16.3 8
WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1; WWC1 5q34-q35.2 8
ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 9; ZDHHC9 Xq26.1 8
ZINC FINGER PROTEIN 103, MOUSE, HOMOLOG OF; ZFP103 2p11.2 8
ZINC FINGER PROTEIN 366; ZNF366 8
ZINC FINGER PROTEIN 384; ZNF384 12p12 8
ZINC FINGER PROTEIN OF CEREBELLUM, 1; ZIC1 3q24 8
ZINC FINGER PROTEIN OF CEREBELLUM, 2; ZIC2 13q32 8
ZINC FINGER PROTEIN OF CEREBELLUM, 3; ZIC3 Xq26.2 8
5-PRIME-@NUCLEOTIDASE, CYTOSOLIC II; NT5C2 10q24.3 7
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 2; ADAMTS2 5q23 7
ACINUS Chr.14 7
ACTIN, ALPHA, CARDIAC MUSCLE; ACTC1 15q14 7
ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP 7
ADDUCIN 1; ADD1 4p16.3 7
ADP-RIBOSYLATION FACTOR-LIKE 3; ARL3 10q23.3 7
ALKALINE PHOSPHATASE, LIVER; ALPL 1p36.1-p34 7
AMPK-RELATED PROTEIN KINASE 5 7
ANGIOMOTIN; AMOT Chr.X 7
ANTHRAX TOXIN RECEPTOR 2; ANTXR2 4q21 7
ARISTALESS-RELATED HOMEOBOX, X-LINKED; ARX Xp22.13 7
ATP CITRATE LYASE; ACLY 17q21.1 7
ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1 7q21.1 7
ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4; ABCG4 11q23.3 7
ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3; ATP2B3 Xq28 7
ATPase, Ca(2+)-TRANSPORTING, UBIQUITOUS; ATP2A3 17p13.3 7
B-CELL LYMPHOMA 6; BCL6 3q27 7
BEADED FILAMENT STRUCTURAL PROTEIN 1; BFSP1 20p12.1-p11.23 7
BENZODIAZAPINE RECEPTOR (PERIPHERAL)-ASSOCIATED PROTEIN 1; BZRAP1 17q23.2 7
BICAUDAL D, DROSOPHILA, HOMOLOG OF, 2; BICD2 9q22.3 7
BONE MORPHOGENETIC PROTEIN 5; BMP5 6p12.1 7
BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II; BMPR2 2q33 7
BREAST CANCER 1 GENE; BRCA1 17q21 7
BROMODOMAIN-CONTAINING PROTEIN 8; BRD8 7
BROTHER OF CDON; BOC 7
CALCITONIN RECEPTOR; CALCR 7q21.3 7
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I-DELTA; CAMK1D 7
CAPPING PROTEIN, BETA; CAPZB 1p36.1 7
CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMOYLASE/DIHYDROOROTASE; CAD 2p21 7
CARBOHYDRATE SULFOTRANSFERASE 1; CHST1 11p11.2-p11.1 7
CARBOHYDRATE SULFOTRANSFERASE 8; CHST8 19q13.1 7
CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1; CLCF1 11q13.3 7
CASEIN KINASE II, ALPHA-2; CSNK2A2 16p13.3-p13.2 7
CATHEPSIN B; CTSB 8p22 7
CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4; CNOT4 7q22-qter 7
CHLORIDE CHANNEL 3; CLCN3 4q33 7
COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA; COPA 1q23-q25 7
COILED-COIL DOMAIN-CONTAINING PROTEIN 73: CCDC73 11p13 7
COILED-COIL DOMAIN-CONTAINING PROTEIN 88A; CCDC88A 2p16.1 7
COILED-COIL DOMAIN-CONTAINING PROTEIN 88C; CCDC88C 7
COLLAGEN, TYPE XXIII, ALPHA-1; COL23A1 5q35 7
COLLECTIN 12; COLEC12 18p11.32 7
COMPLEMENT COMPONENT 3; C3 C3a, INCLUDED 19p13.3-p13.2 7
CRYPTOCHROME 2; CRY2 Chr.11 7
CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED PROTEIN 1; CAND1 7
CXXC FINGER PROTEIN 4; CXXC4 4q22-q24 7
CYCLIN Y; CCNY 10p11.2 7
CYTOCHROME P450 OXIDOREDUCTASE; POR 7q11.2 7
CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 1; CPEB1 7
DEAD/H BOX 9; DDX9 1q25 7
DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS 1p35 7
DICKKOPF, XENOPUS, HOMOLOG OF, 2; DKK2 7
DIHYDROFOLATE REDUCTASE; DHFR DIHYDROFOLATE REDUCTASE PSEUDOGENES, INCLUDED 5q11.2-q13.2 7
DISCS LARGE, DROSOPHILA, HOMOLOG OF, 1; DLG1 3q29 7
DISHEVELLED 3; DVL3 3q27 7
DOCKING PROTEIN 6; DOK6 7
DOPAMINE RECEPTOR D2; DRD2 11q23.1 7
DORSAL ROOT GANGLIA HOMEOBOX; DRGX 10q11.23 7
DYMECLIN; DYM 18q12-q21.1 7
DYNEIN, AXONEMAL, HEAVY CHAIN 3; DNAH3 16p12 7
DYNEIN, AXONEMAL, HEAVY CHAIN 7; DNAH7 7
DYNEIN, AXONEMAL, HEAVY CHAIN 9; DNAH9 17p12 7
EARLY B-CELL FACTOR 4; EBF4 20p13 7
EARLY GROWTH RESPONSE 3; EGR3 8p23-p21 7
EMI DOMAIN-CONTAINING PROTEIN 1; EMID1 7
ETS VARIANT GENE 5; ETV5 3q28 7
EUCHROMATIC HISTONE METHYLTRANSFERASE 1; EHMT1 9q34.3 7
EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 2; EHMT2 7
EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; EEF2 19pter-q12 7
EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT H; EIF3H 8q24.11 7
EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 6; ERCC6 10q11 7
EXOSTOSIN 2; EXT2 11p12-p11 7
EYES ABSENT 2; EYA2 20q13.1 7
F-BOX AND LEUCINE-RICH REPEAT PROTEIN 16; FBXL16 7
FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER C; FAM120C Xp11.2 7
FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC 9q22.3 7
FIBRILLIN 2; FBN2 5q23-q31 7
FIBROBLAST GROWTH FACTOR 2; FGF2 4q25-q27 7
FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2; FRS2 7
FILAMIN C; FLNC 7q32 7
FRIZZLED, DROSOPHILA, HOMOLOG OF, 7; FZD7 2q33 7
FUSE-BINDING PROTEIN-INTERACTING REPRESSOR 7
FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 1; FGD1 Xp11.21 7
G PROTEIN-COUPLED RECEPTOR 124; GPR124 8p12 7
G PROTEIN-COUPLED RECEPTOR 39; GPR39 2q21-q22 7
G PROTEIN-COUPLED RECEPTOR 48; GPR48 11p14-p13 7
G PROTEIN-COUPLED RECEPTOR 85; GPR85 7q31 7
G PROTEIN-COUPLED RECEPTOR KINASE 5; GPRK5 10q24-qter 7
G8 PROTEIN 6p21.3 7
GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4 4p14-q12 7
GDNF FAMILY RECEPTOR ALPHA-2; GFRA2 8p21 7
GLUCOCORTICOID RECEPTOR; GCCR 5q31 7
GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 5; GDPD5 7
GROWTH-ASSOCIATED PROTEIN 43; GAP43 3q13 7
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE; GNAL 18p 7
GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1; GNB1 1pter-p31.2 7
GUANINE NUCLEOTIDE-BINDING PROTEIN, Q POLYPEPTIDE; GNAQ 9q21 7
GUANYLATE CYCLASE 2F, RETINAL; GUCY2F Xq22 7
HEAT-SHOCK 70-KD PROTEIN 9B; HSPA9B 5q31.1 7
HEAT-SHOCK PROTEIN, 90-KD, BETA, 1; HSP90B1 12q23.3 7
HEPARAN SULFATE 2-O-SULFOTRANSFERASE 1; HS2ST1 1p22 7
HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3B1; HS3ST3B1 17p12-p11.2 7
HEPATIC LEUKEMIA FACTOR; HLF HLF/E2A FUSION GENE, INCLUDED 17q22 7
HETEROGENEOUS NUCLEAR RIBOPROTEIN L; HNRNPL 7
HISTONE 1, H2AC; HIST1H2AC 6p21.3 7
HISTONE 1, H3D; HIST1H3D 6p21.3 7
HISTONE 1, H4H; HIST1H4H 6p21.3 7
HISTONE 1, H4K; HIST1H4K 6p22-p21.3 7
HISTONE DEACETYLASE 7A; HDAC7A Chr.12 7
HNF1 HOMEOBOX B; HNF1B 17q12 7
HOMEOBOX GENE HB9; HLXB9 7q36 7
HOMER, DROSOPHILA, HOMOLOG OF, 2; HOMER2 HOMER2A, INCLUDED 15q24.3 7
HRPT2 GENE; HRPT2 1q25-q31 7
HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 2; HCN2 19p13.3 7
IMPORTIN 13; IPO13 7
IMPORTIN 7; IPO7 Chr.11 7
INFLUENZA VIRUS NS1A PROTEIN-BINDING PROTEIN; IVNS1ABP 7
INTERLEUKIN 17 RECEPTOR D; IL17RD 3p14.3-p14.2 7
INTERLEUKIN ENHANCER-BINDING FACTOR 3; ILF3 19p13 7
INVERSIN; INVS 9q31 7
IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 1; IQGAP1 15q26 7
JUMONJI DOMAIN-CONTAINING PROTEIN 3; JMJD3 17p13.1 7
KINESIN HEAVY CHAIN MEMBER 2A; KIF2A 5q12-q13 7
LEUCINE ZIPPER PROTEIN 2; LUZP2 11p14-p13 7
LIGAND OF NUMB PROTEIN X1; LNX1 4q12 7
LIM DOMAIN-BINDING 1; LDB1 10q24-q25 7
LUNAPARK 2q31 7
LYSINE-SPECIFIC DEMETHYLASE 1A; KDM1A 1p36.12 7
LYSINE-SPECIFIC DEMETHYLASE 5A; KDM5A 12p11 7
MAB21, C. ELEGANS, HOMOLOG-LIKE 1; MAB21L1 13q13 7
MAX PROTEIN; MAX 14q23 7
MAX-BINDING PROTEIN; MNT 17p13.3 7
MEDIATOR OF CELL MOTILITY 1; MEMO1 2p22-p21 7
METASTASIS-ASSOCIATED GENE 1; MTA1 14q32.3 7
METHYLENETETRAHYDROFOLATE DEHYDROGENASE, NADP(+)-DEPENDENT 1-LIKE; MTHFD1L 7
MEX3, C. ELEGANS, HOMOLOG OF, A; MEX3A 1q22 7
MICROTUBULE-ASSOCIATED PROTEIN 1A; MAP1A 15q13-qter 7
MITOCHONDRIAL RIBOSOMAL PROTEIN S9; MRPS9 2q12.1 7
MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP 9p21-p12 7
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; MAP4K4 7
MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10; MEGF10 5q23.2 7
MUSASHI, DROSOPHILA, HOMOLOG OF, 1; MSI1 12q24.1-q24.31 7
MYC-ASSOCIATED ZINC FINGER PROTEIN; MAZ 16p11.2 7
MYELIN TRANSCRIPTION FACTOR 1; MYT1 7
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 1; MLLT1 19p13.3 7
MYOSIN VA; MYO5A 15q21 7
MYOSIN VIIA; MYO7A 11q13.5 7
MYOTUBULARIN-RELATED PROTEIN 3; MTMR3 22q12 7
NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 4; NDUFS4 5q11.1 7
NATURAL KILLER TUMOR RECOGNITION SEQUENCE; NKTR 3p23-p21 7
NDP GENE; NDP Xp11.4 7
NEURON NAVIGATOR 1; NAV1 1q31 7
NEURONAL PAS DOMAIN PROTEIN 2; NPAS2 2q13 7
NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT 7q22.2 7
NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN-INTERACTING PROTEIN 2; NUFIP2 17q11.2 7
NUCLEAR RECEPTOR COACTIVATOR 1; NCOA1 2p23 7
NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2 2q22-q23 7
NUDC DOMAIN-CONTAINING PROTEIN 3; NUDCD3 7
NUMB, DROSOPHILA, HOMOLOG OF; NUMB 14q24.3 7
OLFACTOMEDIN 3; OLFM3 7
ORNITHINE DECARBOXYLASE ANTIZYME 2; OAZ2 7
OTOFERLIN; OTOF 2p23-p22 7
OTU DOMAIN-CONTAINING PROTEIN 5; OTUD5 Xp11.23 7
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7 17q21.2 7
PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE-LIKE; PHLPPL 16q22.3 7
PHD FINGER PROTEIN 17; PHF17 7
PHOSPHODIESTERASE 5A; PDE5A 4q26 7
PHOSPHODIESTERASE 8A; PDE8A 15q25.3-q26.1 7
PLATELET-DERIVED GROWTH FACTOR C; PDGFC 4q32 7
PLEOMORPHIC ADENOMA GENE 1; PLAG1 8q12 7
PLEOMORPHIC ADENOMA GENE-LIKE 1; PLAGL1 6q24 7
POLIOVIRUS RECEPTOR-LIKE 4; PVRL4 7
POLY(rC)-BINDING PROTEIN 2; PCBP2 12q13.12-q13.13 7
POLYMERASE II, RNA, SUBUNIT A; POLR2A 17p13.1 7
POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2; KCNT2 1q31.3 7
POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1; KCNH1 1q32-q41 7
POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 1; POU4F1 13q21.1-q22 7
PRECURSOR mRNA-PROCESSING FACTOR 4, S. POMBE, HOMOLOG OF, B; PRPF4B 6p25.2 7
PROFILIN 2; PFN2 3q25.1-q25.2 7
PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1; PRKAA1 5p12 7
PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC 12q24.1-q24.2 7
PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10; PPP1R10 7
PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A; PPP1R3A 7q11.23-q21.11 7
PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM; PPP3CB 10q21-q22 7
PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA ISOFORM 1; PPP3R1 2p16-p15 7
PROTEIN-TYROSINE KINASE PTK7; PTK7 6p21.1-p12.2 7
PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 12; PTPN12 7q11.23 7
PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5; PTPN5 11p15.2-p15.1 7
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA; PTPRA 20p13 7
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN 2q35-q36.1 7
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, U; PTPRU 12p13.3-p13.2 7
RAB11 FAMILY-INTERACTING PROTEIN 5; RAB11FIP5 2p13-p12 7
RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1; RGL1 1q25.3 7
RAN-BINDING PROTEIN 9; RANBP9 6p23 7
RAS HOMOLOG ENRICHED IN BRAIN; RHEB 7q36 7
RAS-ASSOCIATED PROTEIN 28; RAB28 4p15.33 7
RB1-INDUCIBLE COILED-COIL 1; RB1CC1 8q11 7
REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP 5q12.3 7
RETICULON 4 RECEPTOR; RTN4R 22q11 7
RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5 14q12 7
RIBOSOMAL PROTEIN L13; RPL13 7
RING FINGER AND FYVE-LIKE DOMAIN CONTAINING 1; RFFL 17q12 7
RING FINGER PROTEIN 43; RNF43 17q23.2 7
RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 2; RFWD2 1q24.1 7
RNA POLYMERASE I AND TRANSCRIPT RELEASE FACTOR; PTRF 7
RNA-BINDING REGION-CONTAINING PROTEIN 2; RNPC2 7
RUN AND FYVE DOMAINS-CONTAINING PROTEIN 3; RUFY3 7
RUNT-RELATED TRANSCRIPTION FACTOR 3; RUNX3 1p36 7
SACSIN; SACS 13q12 7
SARCALUMENIN; SRL 16p13.3 7
SEC24-RELATED GENE FAMILY, MEMBER A; SEC24A 7
SEMAPHORIN 3A; SEMA3A 7
SEMAPHORIN 3D; SEMA3D 7
SEMAPHORIN 7A; SEMA7A 15q22.2-q23 7
SERINE/THREONINE PROTEIN KINASE 24; STK24 13q31.2-q32.3 7
SERINE/THREONINE PROTEIN KINASE 39; STK39 2q24.3 7
SET TRANSLOCATION, MYELOID LEUKEMIA-ASSOCIATED; SET 9q34 7
SHROOM FAMILY MEMBER 3; SHROOM3 4q21.1 7
SMALL CAJAL BODY-SPECIFIC RNA 15; SCARNA15 15q25.2 7
SMG7, C. ELEGANS, HOMOLOG OF; SMG7 1q25 7
SMOOTHELIN; SMTN 22q12.3 7
SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 4; SLC12A4 16q22.1 7
SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 26; SLC25A26 3p14.3 7
SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 8; SLC4A8 Chr.12 7
SOLUTE CARRIER FAMILY 41, MEMBER 1; SLC41A1 1q31-q32 7
SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 2; SLC43A2 17p13.3 7
SORCS RECEPTOR 2; SORCS2 4p16.1 7
SORTING NEXIN 27; SNX27 1q21.3 7
SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE; SMPD3 7
SPLICING FACTOR, ARGININE/SERINE-RICH, 10; SFRS10 3q26.2-q27 7
SPLICING FACTOR, ARGININE/SERINE-RICH, 3; SFRS3 6p21 7
SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2 13q31.1 7
ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 5; ST6GALNAC5 1p31.1 7
ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 2; ST8SIA2 15q26 7
STONIN 2 7
SUPERKILLER VIRALICIDIC ACTIVITY 2, S. CEREVISIAE, HOMOLOG-LIKE; SKIV2L 6p21 7
SUPPRESSOR OF MEK1, DICTYOSTELIUM, HOMOLOG OF, 2; SMEK2 7
SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1 6q25 7
SYNOVIAL SARCOMA TRANSLOCATION, CHROMOSOME 18; SS18 18q11.2 7
SYNTROPHIN, BETA-2; SNTB2 16q22-q23 7
TAF2 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 150-KD; TAF2 7
TALIN 1; TLN1 9p 7
TELOMERASE RNA COMPONENT; TERC 3q21-q28 7
THYROID ADENOMA-ASSOCIATED GENE; THADA 2p21 7
TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3 22q12.1-q13.2 7
TNF RECEPTOR-ASSOCIATED FACTOR 2; TRAF2 7
TOUSLED-LIKE KINASE 2; TLK2 7
TRANSCRIPTION ELONGATION REGULATOR 1; TCERG1 5q31 7
TRANSCRIPTION FACTOR AP2-BETA; TFAP2B 6p12 7
TRANSCRIPTION FACTOR Sp8; SP8 7p21 7
TRANSCRIPTION FACTOR YY1; YY1 14q 7
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3; TRPC3 7
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 6; TRPM6 9q22 7
TRF1-INTERACTING, ANKYRIN-RELATED ADP-RIBOSE POLYMERASE; TNKS Chr.8 7
TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 4; TUBGCP4 15q15 7
UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7; GALNT7 4q31.1 7
URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 8; UGT8 4q26 7
UTP11-LIKE PROTEIN; UTP11L 1p34.3 7
V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ABL2 1q24-q25 7
V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN G; MAFG 17q25 7
V-MAF MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN B; MAFB 20q11.2-q13.1 7
VACCINIA-RELATED KINASE 2; VRK2 2p16-p15 7
VACUOLAR PROTEIN SORTING 4, YEAST, HOMOLOG OF, A; VPS4A 16q22 7
VALOSIN-CONTAINING PROTEIN; VCP 9p13-p12 7
WD REPEAT-CONTAINING PROTEIN 22; WDR22 14q24.1-q24.2 7
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9A; WNT9A 1q42 7
WINGS APART-LIKE PROTEIN, DROSOPHILA, HOMOLOG OF; WAPAL 10q23.2 7
X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX Xq13.2 7
ZINC FINGER AND BTB DOMAIN-CONTAINING 4; ZBTB4 17p13.1 7
ZINC FINGER AND RING FINGER PROTEIN 1; ZNRF1 16q23.1 7
ZINC FINGER PROTEIN 219; ZNF219 14q11 7
ZINC FINGER PROTEIN 278; ZNF278 22q12 7
ZINC FINGER PROTEIN 36-LIKE 1; ZFP36L1 14q22-q24 7
ZINC FINGER, AN1-TYPE, DOMAIN-CONTAINING PROTEIN 5; ZFAND5 9q13-q21 7
ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 21; ZSCAN21 7q21-q22 7
4-@AMINOBUTYRATE AMINOTRANSFERASE; ABAT 16p13.3 6
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 19; ADAMTS19 6
A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5; ADAMTS5 21q21-q22 6
ABELSON HELPER INTEGRATION SITE 1; AHI1 6q23.3 6
ABL INTERACTOR 2 6
ACTIN, ALPHA-2, SMOOTH MUSCLE, AORTA; ACTA2 10q22-q24 6
ACTIN, BETA-LIKE, 1; ACTBL1 6
ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 1; ABLIM1 10q25 6
ACTININ, ALPHA-3; ACTN3 ACTN3 DEFICIENCY, INCLUDED 11q13-q14 6
ACTIVIN A RECEPTOR, TYPE IB; ACVR1B 12q13 6
ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA-1 SUBUNIT; AP1B1 22q12 6
ADENOSINE MONOPHOSPHATE DEAMINASE 2; AMPD2 1p13.3 6
ADENYLATE CYCLASE 2; ADCY2 5p15.3 6
ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2; ALDH1A2 Chr.15 6
ALG9, S. CEREVISIAE, HOMOLOG OF; ALG9 11q23 6
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 2; APBB2 4p14 6
ANGIOPOIETIN 1; ANGPT1 8q22 6
ANGIOPOIETIN-LIKE 2; ANGPTL2 6
ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28; ANKRD28 3p25.1 6
ANTIZYME INHIBITOR 1; AZIN1 8q22.3 6
APC GENE 5q21-q22 6
ARISTALESS-LIKE 4, MOUSE, HOMOLOG OF; ALX4 11p11.2 6
ARKADIA, MOUSE, HOMOLOG OF 6
ARMADILLO REPEAT GENE DELETED IN VCFS; ARVCF 22q11 6
ARYLHYDROCARBON RECEPTOR REPRESSOR; AHRR 5p15.3 6
AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4A; ARID4A 14q23.1 6
ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1; ATP2B1 12q21-q23 6
ATPase, CLASS I, TYPE 8B, MEMBER 2; ATP8B2 1q21.3 6
ATPase, CLASS VI, TYPE 11A; ATP11A 13q34 6
ATPase, CLASS VI, TYPE 11C; ATP11C 6
ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2 1q21-q23 6
ATTRACTIN; ATRN 20p13 6
BarH-LIKE HOMEOBOX GENE 2; BARX2 11q25 6
BCL2-ASSOCIATED ATHANOGENE 1; BAG1 9p12 6
BCL2-LIKE 11; BCL2L11 2q12-q13 6
BETA-ADRENERGIC RECEPTOR KINASE 1; ADRBK1 11cen-q13 6
BH3-INTERACTING DOMAIN DEATH AGONIST; BID 22q11.2 6
BICAUDAL D, DROSOPHILA, HOMOLOG OF, 1; BICD1 12p11.2-p11.1 6
BONE MORPHOGENETIC PROTEIN 2; BMP2 20p12 6
BONE MORPHOGENETIC PROTEIN 7; BMP7 20q13.1-q13.3 6
BRIDGING INTEGRATOR 3; BIN3 8p21.3 6
BROMODOMAIN- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 3; BRWD3 Xq13 6
BROMODOMAIN-CONTAINING PROTEIN 1; BRD1 22q13 6
BRUNO-LIKE 6; BRUNOL6 15q24 6
BTAF1 RNA POLYMERASE II, B-TFIID TRANSCRIPTION FACTOR-ASSOCIATED, 170-KD; BTAF1 10q22-q23 6
BUDDING UNINHIBITED BY BENZIMIDAZOLES 3, S. CEREVISIAE, HOMOLOG OF; BUB3 10q24-q26 6
C-TERMINAL DOMAIN OF RNA POLYMERASE II POLYPEPTIDE A, SMALL PHOSPHATASE OF, 1; CTDSP1 2q34 6
CALCIUM-BINDING ATOPY-RELATED AUTOANTIGEN 1; CBARA1 6
CALCIUM-BINDING PROTEIN 39; CAB39 2q37.1 6
CALSENILIN; CSEN 6
CASEIN KINASE I, EPSILON; CSNK1E 22q12-q13 6
CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 11; CARD11 7p22 6
CEH10 HOMEODOMAIN-CONTAINING HOMOLOG; CHX10 14q24.3 6
CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 5; CCT5 5p15.2 6
CHEMOKINE-LIKE FACTOR SUPERFAMILY, MEMBER 4; CKLFSF4 6
CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 5; CHD5 1p36 6
CHROMOSOME 10 OPEN READING FRAME 26; C10ORF26 10q24.32 6
CHROMOSOME 14 OPEN READING FRAME 4; C14ORF4 14q24.3 6
CHROMOSOME 21 OPEN READING FRAME 29; C21ORF29 21q22.3 6
CLATHRIN, HEAVY POLYPEPTIDE-LIKE 1; CLTCL1 22q11.2 6
COLLAGEN, TYPE IV, ALPHA-2; COL4A2 13q34 6
COLLAGEN, TYPE IV, ALPHA-3; COL4A3 2q36-q37 6
COLLAGEN, TYPE V, ALPHA-2; COL5A2 2q31 6
COLLAGEN, TYPE XIX, ALPHA-1; COL19A1 6q12-q14 6
COLLAGEN, TYPE XXVIII, ALPHA-1; COL28A1 7p21.3 6
COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I 1p32 6
CONTACTIN 3; CNTN3 3p26 6
CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4 6
COPINE I; CPNE1 6
COPINE V; CPNE5 6p21 6
CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 3; CBFA2T3 16q24 6
CORE-BINDING FACTOR, BETA SUBUNIT; CBFB 16q22 6
CUBILIN; CUBN 10p12.1 6
CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 1; CUGBP1 11p11 6
CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3 8q21-q22 6
CYCLIN C; CCNC 6q21 6
CYCLIN M2; CNNM2 10q24.33 6
CYCLIN M4; CNNM4 2q11.2 6
CYCLIN T2; CCNT2 2p14-q21.3 6
CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1 6
D-TYROSYL-tRNA DEACYLASE 1, S. CEREVISIAE, HOMOLOG OF; DTD1 20p11 6
DACHSOUS, DROSOPHILA, HOMOLOG OF, 1; DCHS1 6
DAPPER, ANTAGONIST OF BETA-CATENIN, 3; DACT3 19q13.3 6
DAZ-ASSOCIATED PROTEIN 1; DAZAP1 6
DEATH-ASSOCIATED PROTEIN KINASE 1; DAPK1 9q34.1 6
DEIODINASE, IODOTHYRONINE, TYPE II; DIO2 14q24.3 6
DELTA-LIKE 1; DLL1 6
DENTICLELESS, DROSOPHILA, HOMOLOG OF; DTL 1q32.1-q32.2 6
DIGEORGE SYNDROME CRITICAL REGION GENE 2; DGCR2 22q11.2 6
DISCS LARGE, DROSOPHILA, HOMOLOG OF, 3; DLG3 Xq13.1 6
DISPATCHED, DROSOPHILA, HOMOLOG OF, 1; DISP1 1q42 6
DISTAL-LESS HOMEOBOX 1; DLX1 2q32 6
DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 14; DNAJC14 12q13.1-q13.2 6
DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5 5p15-p14 6
DYSKERIN; DKC1 Xq28 6
ECOTROPIC VIRAL INTEGRATION SITE 1; EVI1 3q26 6
ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 5; ELOVL5 6p12 6
ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 6; ELOVL6 4q25 6
EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 3; ELAVL3 19p13.2 6
ENIGMA-LIKE LIM DOMAIN PROTEIN 4q22 6
EPSIN 2; EPN2 Chr.17 6
ETHANOLAMINE KINASE 1; ETNK1 12p12.1-p11.2 6
EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT J; EIF3J 15q15.3 6
EUKARYOTIC TRANSLATION INITIATION FACTOR 5A; EIF5A 17p13-p12 6
F-BOX AND LEUCINE-RICH REPEAT PROTEIN 11; FBXL11 Chr.11 6
F-BOX AND LEUCINE-RICH REPEAT PROTEIN 19; FBXL19 6
FACTOR XIII, A1 SUBUNIT; F13A1 6p25-p24 6
FAR UPSTREAM ELEMENT-BINDING PROTEIN 3; FUBP3 6
FERMITIN FAMILY (DROSOPHILA) HOMOLOG 2; FERMT2 14q22.1 6
FIBROBLAST ACTIVATION PROTEIN, ALPHA; FAP 2q23 6
FIBROBLAST GROWTH FACTOR 10; FGF10 5p13-p12 6
FIBROBLAST GROWTH FACTOR 8; FGF8 10q24 6
FORKHEAD BOX G1; FOXG1 14q13 6
FORKHEAD BOX O1A; FOXO1A 13q14.1 6
FOUR-AND-A-HALF LIM DOMAINS 1; FHL1 Xq27.2 6
FRATAXIN; FXN 9q13 6
G PROTEIN-COUPLED RECEPTOR 177; GPR177 1p31.3 6
G1- TO S-PHASE TRANSITION 1; GSPT1 16p13.1 6
GAMETOGENETIN-BINDING PROTEIN 2; GGNBP2 17q12-q21.1 6
GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1; GABRA1 5q34-q35 6
GAP JUNCTION PROTEIN, ALPHA-1; GJA1 6q21-q23.2 6
GATA-BINDING PROTEIN 2; GATA2 3q21 6
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C; GRIN2C 17q25 6
GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2 3p21.2-p21.1 6
GOLGI APPARATUS PROTEIN 1; GLG1 16q22-q23 6
GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 1; GGA1 22q13.31 6
GON4-LIKE PROTEIN; GON4L 6
GRIP AND COILED-COIL DOMAINS-CONTAINING PROTEIN 1; GCC1 7q32.1 6
GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L 22q11.2 6
HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1; HSP90AA1 14q32.2 6
HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 1; HECW1 6
HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A 20q12-q13.1 6
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1; HNRNPA2B1 7p15 6
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D-LIKE PROTEIN; HNRNPDL 4q13-q21 6
HIGH MOBILITY GROUP BOX 1; HMGB1 13q12 6
HIGHLY ACCELERATED REGION GENE 1A; HAR1A 20q13.33 6
HIGHLY ACCELERATED REGION GENE 1B; HAR1B 20q13.33 6
HIPPOCALCIN; HPCA 1p35-p34.2 6
HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; HISPPD1 5q21.1 6
HISTONE 1, H1B; HIST1H1B 6p22-p21.3 6
HISTONE 1, H2AM; HIST1H2AM 6p22-p21.3 6
HISTONE 1, H2BG; HIST1H2BG 6p21.3 6
HISTONE 1, H2BL; HIST1H2BL 6p22-p21.3 6
HISTONE 3, H3; HIST3H3 1q42 6
HISTONE ACETYLTRANSFERASE 1; HAT1 2q31.2-q33.1 6
HLA-B-ASSOCIATED TRANSCRIPT 1; BAT1 6p21.3 6
HOMEOBOX 3D; HOX3D 12q13 6
HOMEOBOX A10; HOXA10 7p15-p14.2 6
HOMEOBOX A11, ANTISENSE 7p15-p14.2 6
HOMEOBOX C4; HOXC4 12q13 6
HOMEOBOX C6; HOXC6 12q13 6
HOMEODOMAIN-INTERACTING PROTEIN KINASE 3; HIPK3 11p13 6
HOST CELL FACTOR C1; HCFC1 Xq28 6
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 1; HIVEP1 6p24-p22.3 6
IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4B; IGSF4B 1q21.2-q22 6
INAD-LIKE; INADL 1p31.3 6
INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; ITPK1 6
INTERLEUKIN 8 RECEPTOR, BETA; IL8RB 2q35 6
INTERSECTIN 1; ITSN1 21q22.1-q22.2 6
IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 2; IQGAP2 5q11-q13 6
ISOLEUCYL-tRNA SYNTHETASE; IARS 9q21 6
JUNCTION PLAKOGLOBIN; JUP 17q21 6
K(LYSINE) ACETYLTRANSFERASE 2A; KAT2A 17q21 6
KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1; KHDRBS1 6
KINESIN FAMILY MEMBER 13B; KIF13B Chr.8 6
KIT LIGAND; KITLG 12q22 6
KRUPPEL-LIKE FACTOR 9; KLF9 9q13 6
LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3 12q14 6
LEPRECAN-LIKE 1; LEPREL1 6
LEUCINE-RICH REPEAT KINASE 1; LRRK1 15q26.3 6
LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6A; LRRN6A 15q24 6
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A; LRRC8A 9q34.13 6
LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 2; LIMS2 6
LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA; LMX1A 1q22-q23 6
LIPOMA HMGIC FUSION PARTNER; LHFP LHFP/HMGIC FUSION GENE, INCLUDED 13q12 6
LSM12, S. CEREVISIAE, HOMOLOG OF; LSM12 17q21.31 6
LUC7, S. CEREVISIAE, HOMOLOG OF; LUC7L 16p13.3 6
MATRIX METALLOPROTEINASE 14; MMP14 14q11-q12 6
MATRIX METALLOPROTEINASE 16; MMP16 8q21 6
MET PROTOONCOGENE; MET 7q31 6
METAL-REGULATORY TRANSCRIPTION FACTOR 2; MTF2 1p22.1 6
METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MALAT1 11q13.1 6
MEX3, C. ELEGANS, HOMOLOG OF, C; MEX3C 18q21.2 6
MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 2; MAST2 1p34.1 6
MISSHAPEN/NIK-RELATED KINASE 1; MINK1 17p13.1 6
MITOGEN-ACTIVATED PROTEIN KINASE 6; MAPK6 6
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11; MAP3K11 11q13.1-q13.3 6
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5; MAP3K5 6q22.33 6
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3; MAP4K3 6
MYOSIN X; MYO10 5p15.1-p14.3 6
MYOSIN XVIIIB; MYO18B 22q12.1 6
MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT; MYH2 17p13.1 6
MYOTUBULARIN-RELATED PROTEIN 14; MTMR14 3p25.3 6
NEUROLIGIN 3; NLGN3 Xq13 6
NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1 1q21-q22 6
NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NMNAT2 6
NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NNT 5p13.1-cen 6
NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2; NFATC2 20q13.2-q13.3 6
NUCLEAR RECEPTOR COACTIVATOR 2; NCOA2 6
NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1; NR2F1 5q14 6
NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; NOC3L 10q24 6
NUCLEOPORIN, 98-KD; NUP98 NUP98-NUP96 PRECURSOR PROTEIN, INCLUDED 11p15 6
NUCLEOPORIN-LIKE 1; NUPL1 13q12.1 6
NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1; NAP1L1 12q21.2 6
OCRL GENE; OCRL Xq26.1 6
OLFACTOMEDIN 1; OLFM1 Chr.9 6
OPIOID RECEPTOR-LIKE 1; OPRL1 6
OTU DOMAIN-CONTAINING PROTEIN 7A; OTUD7A 15q13.3 6
OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B 1q21.2 6
p21-ACTIVATED KINASE 3; PAK3 Xq21.3-q24 6
PAIRED-LIKE HOMEOBOX 2B; PHOX2B 4p12 6
PANTOTHENATE KINASE 2; PANK2 20p13-p12.3 6
The icons used in this page are a part of Tango Desktop Project created by Tango Desktop Project
which are available under CC BY-SA License.
This site uses Yahoo! User Interface Library (YUI) which is available under BSD License.